THIP KPI 2024

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 Thailand Hospital Indicator Program: THIP KPI KPI DICTIONARY 2024 Thail TH

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 0

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P i ÙĈîĈ øąïïÿćøÿîđìýđðøĊ÷ïđìĊ÷ïüĆéøąéĆïÙčèõćóēøÜó÷ćïćú (Thailand Hospital Indicator Program : THIP) đðŨîøąïïÖćøđðøĊ÷ïđìĊ÷ïêĆüßĊĚüĆéÙčèõćó×ĂÜēøÜó÷ćïćúìĊęñĎšøć÷ÜćîÝąĕéšìøćïÙŠć×ĂÜêî đðøĊ÷ïđìĊ÷ïÖĆïÙŠć Percentile ×ĂÜÖúčŠöđðøĊ÷ïđìĊ÷ï đóČęĂĔĀšēøÜó÷ćïćúÿćöćøëđðøĊ÷ïđìĊ÷ïñúúĆóíŤÖćø óĆçîćéšćîêŠćÜ ė ÖĆïēøÜó÷ćïćúĂČęîìĊęöĊúĆÖþèąĔÖúšđÙĊ÷ÜÖĆîìøćïüŠćêîđĂÜĂ÷ĎŠêøÜĕĀîđöČęĂđìĊ÷ïÖĆïÖúčŠöđðŨî ÖćøÖøąêčšîÖćøóĆçîćìĊęöĊóúĆÜĒúąÿćöćøëÙšîĀćēøÜó÷ćïćúìĊęöĊĒîüðäĉïĆêĉìĊęéĊ (good practice) îĈöćĒúÖđðúĊę÷îđøĊ÷îøĎšÖĆî ēÙøÜÖćøóĆçîćøąïïÿćøÿîđìýđðøĊ÷ïđìĊ÷ïüĆéøąéĆïÙčèõćóēøÜó÷ćïćú đøĉęöéĈđîĉîÖćøĔîðŘ2550 ēé÷ÙüćöøŠüööČĂøąĀüŠćÜÿëćïĆîøĆïøĂÜÙčèõćóÿëćîó÷ćïćú (ĂÜÙŤÖćøöĀćßî) ÖĆïđÙøČĂ׊ć÷ēøÜó÷ćïćú ÿëćïĆîĒóì÷ýćÿêøŤĒĀŠÜðøąđìýĕì÷ (UhosNet) ēé÷Öćø×ĆïđÙúČęĂî×ĂÜÙèąÖøøöÖćøøąïïÿćøÿîđìý đðøĊ÷ïđìĊ÷ïüĆéøąéĆïÙčèõćóēøÜó÷ćïćúöćĂ÷ŠćÜêŠĂđîČęĂÜ Ēúąĕéš×÷ć÷ñúÖćøĔßšÜćîĂ÷ŠćÜÖüšćÜ×üćÜÿĈĀøĆï ēøÜó÷ćïćúìčÖøąéĆï×ĂÜðøąđìýĕì÷ĔîðŦÝÝčïĆî öĊüĆêëčðøąÿÜÙŤđóČęĂ 1) ÿŠÜđÿøĉöĔĀšÿëćîó÷ćïćú Ĕßšðøąē÷ßîŤ ÝćÖÖćøđðøĊ÷ïđìĊ÷ïđóČęĂÖćø÷ÖøąéĆïñúúĆóíŤ×ĂÜĂÜÙŤÖø 2) óĆçîćêĆüßĊĚüĆéđðøĊ÷ïđìĊ÷ïĔîÖćøüĆéñúúĆóíŤìĊęđðŨî ðøąē÷ßîŤêŠĂÖćøóĆçîćÙčèõćó×ĂÜÿëćîó÷ćïćú 3) óĆçîćĂÜÙŤÙüćöøĎšÝćÖÖćøðäĉïĆêĉìĊęéĊ/đðŨîđúĉý ×ĂÜđÙøČĂ׊ć÷ÿëćîó÷ćïćúĒúąåćîךĂöĎúñúúĆóíŤÖćøóĆçîćÙčèõćóÿϊךĂđÿîĂĒîąđßĉÜîē÷ïć÷ 4) óĆçîć ÖúĕÖđÙøČęĂÜöĂéČ ĉÝĉìĆúđìÙēîēú÷ĊøąïïÿćøÿîđìýđðøĊ÷ïđìĊ÷ïüĆéøąéĆïÙčèõćóēøÜó÷ćïćú êĆüßĊĚüĆéđðøĊ÷ïđìĊ÷ï THIP öĊĂÜÙŤðøąÖĂïÿĈÙĆâ ĕéšĒÖŠ 1) đðŨîêĆüßĊĚüĆéìĊęöĊÙüćöÿĈÙĆâêŠĂÙčèõćóĔî øąïï×ĂÜēøÜó÷ćïćú 2) đðŨîêĆüßĊĚüĆéìĊęÿŠÜÿĆââćèßĆéđÝîđóČęĂÖćøđðøĊ÷ïđìĊ÷ï 3) ÿćöćøëĂšćÜĂĉÜĕéšìćÜ üĉßćÖćø 4) öĊðøąē÷ßîŤêŠĂÖøąïüîÖćøóĆçîćÙčèõćó 5) öĊĂÜÙŤðøąÖĂïìĊęöĊÙčèÿöïĆêĉĔîøąéĆïìĊę÷ĂöøĆïĕéš ÿĈĀøĆïÖćøêĆéÿĉîĔÝđßĉÜÖćøÝĆéÖćø 6) đðŨîĕðĕéšÝøĉÜĒúąÙčšöÙŠćĔîÖćøđÖĘïךĂöĎúĔĀšĕéšëĎÖêšĂÜ 7) ÙĈîċÜëċÜ ñúÖøąìïêŠĂñĎšêĆéÿĉîĔÝĒúąñĎšøĆïñĉéßĂïĔîÖćøðäĉïĆêĉÜćî ēé÷ĔßšÙĈÝĈÖĆéÙüćööćêøåćîÿĈĀøĆïēøÜó÷ćïćú ÿöćßĉÖĔîÖćøøć÷ÜćîךĂöĎúêĆüßĊĚüĆéêćöߊüÜđüúćìĊęÖĈĀîé ēé÷øĀĆÿēøÙ/ĀĆêëÖćøìĊęđÖĊę÷üךĂÜĔîøć÷ÖćøêüßĆ ĊĚüĆé ĂšćÜĂĉÜÝćÖïĆâßĊÝĈĒîÖēøÙøąĀüŠćÜðøąđìý ÞïĆïðøąđìýĕì÷ (ICD-10-TM 2016) ïĆâßĊêĆüßĊĚüĆéđðøĊ÷ïđìĊ÷ïÞïĆïîĊĚöĊÖćøðøĆïÖćøøąïčßČęĂêĆüßĊĚüĆéĔĀšÿĂéÙúšĂÜĒúąđðŨîöćêøåćî ÝĆéìĈ ×ċĚîÿĈĀøĆïēøÜó÷ćïćúÿöćßĉÖøąïï đóČęĂĂšćÜĂĉÜÖćøÝĆéđÖĘïךĂöĎúêĆüßĊĚüĆéìĊęđðŨîöćêøåćîđéĊ÷üÖĆî öčŠÜĀüĆÜĔĀšđÖĉé ÖćøĔßšðøąē÷ßîŤÝćÖêĆüßĊĚüĆéĂ÷ŠćÜöĊÙčèÙŠć éĆÜÙĈÖúŠćüìĊęüŠć “ÙüćööĊÙčèÙŠć×ĂÜÖćøĔßšêĆüßĊĚüĆéîĆĚî ݹߊü÷ĔĀšđÖĉéÖćø×ĆïđÙúČęĂîÖćøóĆçîćÙčèõćó ĕðÿĎŠÙüćööĊ öćêøåćî ĒúąđÖĉéÙüćöðúĂéõĆ÷ÖĆïñĎšðśü÷ĕéšĔîìĊęÿčé” ÿëćïĆîøĆïøĂÜÙčèõćóÿëćîó÷ćïćú (ĂÜÙŤÖćøöĀćßî) ÖĆî÷ć÷î 2565

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P ii ÿćøïĆâ ÙĈîĈ .................................................................................................................................................... i ÿćøïĆâ ............................................................................................................................................... ii ĒîüìćÜÖćøÝĆéÖúčŠöđðøĊ÷ïđìĊ÷ï×ĂÜēøÜó÷ćïćúÿöćßĉÖ THIP ........................................................... 1 øć÷ÖćøïĆâßĊêĆüßĊĚüĆéđðøĊ÷ïđìĊ÷ï ðŘÜïðøąöćè 2566 ........................................................................ 2 üĉíĊÖćøĔßšÜćîøĀĆÿêĆüßĊĚüĆéđðøĊ÷ïđìĊ÷ï THIP ........................................................................................ 4 ĒñîñĆÜõćóøüö ÖúčŠöêĆüßĊĚüĆéøć÷ēøÙ (Disease: D) ..................................................................... 5 ĒñîñĆÜõćóøüö ÖúčŠöêĆüßĊĚüĆéÖøąïüîÖćøéĎĒúñĎšðśü÷ìĊęÿĈÙĆâ (Care process: C) ..................... 21 ĒñîñĆÜõćóøüö ÖúčŠöêĆüßĊĚüĆéøąïïÜćîÿĈÙĆâ (System: S) ....................................................... 27 ĒñîñĆÜõćóøüö ÖúčŠöêĆüßĊĚüĆéÿøšćÜđÿøĉöÿč×õćó (Health Promotion: H) ................................ 34 ĒñîñĆÜõćóøüö ÖúčŠöêĆüßĊĚüĆéÖúčŠöēøÙìĊęÙüøøĆÖþćĒïïñĎšðśü÷îĂÖ (Ambulatory care: A) ................... 38 Āöüé DH: Cardiovascular disease (Heart disease:H) ...................................................... 39 ðøąđõì DH01 Acute coronary syndrome (ACS) .............................................................. 39 ðøąđõì DH03 Heart Failure .................................................................................................. 61 ðøąđõì DH04 Atrial fibrillation ............................................................................................ 64 Āöüé DN: Neurovascular disease (N) ................................................................................ 67 ðøąđõì DN01 Stroke .............................................................................................................. 67 ðøąđõì DN03 Head injury ..................................................................................................... 76 Āöüé DR: Respiratory disease (R) ....................................................................................... 79 ðøąđõì DR01 Pneumonia ..................................................................................................... 79 ðøąđõì DR02 TB (mycobacterium tuberculosis)............................................................. 82 ðøąđõì DR04 COPD ................................................................................................................ 89 Āöüé DC: Chronic Disease (C) ............................................................................................. 92 ðøąđõì DC01 Diabetes Mellitus .......................................................................................... 92 ðøąđõì DC02 Hypertension ................................................................................................. 96 ðøąđõì DC03 HIV ................................................................................................................. 100 ðøąđõì DC04 Cancer .......................................................................................................... 106 ðøąđõì DC05 Chronic Kidney Disease ............................................................................ 109 Āöüé DO: Musculoskeletal disease (O) ......................................................................... 113 ðøąđõì DO02 Hip ................................................................................................................ 113 97 101 107 110 114 114

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P iii ðøąđõì DO03 Knee ............................................................................................................. 116 Āöüé DG: Gastrointestinal disease (G) ........................................................................... 119 ðøąđõì DG01 UGIH .............................................................................................................. 119 ðøąđõì DG02 Appendix ..................................................................................................... 121 Āöüé DS: Substance use disorder (S) ............................................................................ 125 ðøąđõì DS01 Methamphetamine group ........................................................................ 125 ðøąđõì DS02 Alcohol droup ............................................................................................. 126 ðøąđõì DS03 Tobacco group ............................................................................................ 127 ðøąđõì DS04 Opioid group ............................................................................................... 128 Āöüé DE: Center of excellence (E) ................................................................................. 129 ðøąđõì DE01 Breast cancer ............................................................................................... 129 ðøąđõì DE05 Stem cell transplantation ........................................................................ 131 ðøąđõì DE08 Thalassemia ................................................................................................. 132 ðøąđõì DE12 Cleft lip –Cleft palate and craniofacial disease ................................. 133 ðøąđõì DE13 Infertility ....................................................................................................... 135 ðøąđõì DE14 Gastrointestinal Scopy .............................................................................. 141 ðøąđõì DE16 Conductive and sensorineural hearing loss ......................................... 149 Āöüé DM: Meantal health (M) ......................................................................................... 150 ðøąđõì DM01 Global development delay (GDD) ........................................................ 150 ðøąđõì DM02 Autism spectrum disorder (ASD) ........................................................... 153 ðøąđõì DM03 Cerebral palsy ............................................................................................ 156 ðøąđõì DM04 Child and adolescent psychiatry .......................................................... 158 Āöüé CM: Maternal and child health care process (M) ............................................ 160 ðøąđõì CM01 Maternal health care process ................................................................ 160 ðøąđõì CM02 Child health care process ....................................................................... 171 Āöüé CA: Anesthesia care process (A) .......................................................................... 180 ðøąđõì CA01 Anesthesia care process ........................................................................... 180 Āöüé CO: Operative care process (O) ............................................................................ 185 ðøąđõì CO01 Operative care process ............................................................................ 185 Āöüé CG: General care process (G) ................................................................................ 188 ðøąđõì CG01 Pressure ulcer/injury care process ......................................................... 188 Āöüé CE: Emergency care process (E) ........................................................................... 194 117 120 120 122 126 126 127 128 129 130 130 132 133 134 136 142 150 151 151 154 157 159 161 161 172 180 180 185 185 188 188 194

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P iv ðøąđõì CE01 ER care process ........................................................................................... 194 Āöüé CI: Intensive care process (I) ................................................................................. 199 ðøąđõì CI01 Sepsis care process ..................................................................................... 199 Āöüé CP: Psychiatry care process (P) ............................................................................. 200 ðøąđõì CP01 Child and adolescent psychiatry care process ................................... 200 ðøąđõì CP02 Nuerodevelopmental disorder care process ....................................... 201 Āöüé SI: Infection control system (I) ............................................................................. 202 ðøąđõì SI01 Ventilator associated pneumonia (VAP) ................................................ 202 ðøąđõì SI02 Blood stream infection (BSI) ..................................................................... 205 ðøąđõì SI03 Catheter-Associated Urinary Tract Infection (CAUTI) .......................... 208 Āöüé SL: Laboratory system (L) ...................................................................................... 211 ðøąđõì SL01 Blood bank ................................................................................................... 211 Āöüé SH: Human resource system (H) .......................................................................... 212 ðøąđõì SH01 Human resource management (HRM)................................................... 212 ðøąđõì SH02 Human Resource Development (HRD).................................................. 219 ðøąđõì SH03 Human resource and occupational health (HRH) .............................. 235 Āöüé SF: Financial system (F) .......................................................................................... 244 ðøąđõì SF01 Financial ........................................................................................................ 244 Āöüé SC: Customer service system (C) ......................................................................... 250 ðøąđõì SC01 Customer service ........................................................................................ 250 Āöüé SG: Governance system (G) ................................................................................... 256 ðøąđõì SG01 Governance ................................................................................................. 256 Āöüé SS: Sterilization system (S) .................................................................................... 257 ðøąđõì SS01 Sterilization and service system ............................................................. 257 Āöüé SM: Medication system (M) ................................................................................... 260 ðøąđõì SM01 Medication use ........................................................................................... 260 ðøąđõì SM02 Medication management ......................................................................... 262 Āöüé HE: Employee health promotion (E) ................................................................... 264 ðøąđõì HE01 Employee health status ........................................................................... 264 Āöüé HC: Customer health promotion (C) ................................................................... 270 ðøąđõì HC01 Customer health status ............................................................................ 270 Āöüé HH: Health Promotion ............................................................................................ 272 194 199 199 200 200 201 202 202 205 208 211 211 212 212 219 235 244 244 250 250 256 256 257 257 260 260 262 264 264 270 270 272

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P v ðøąđõì HH01 Tobacco Use ............................................................................................... 272 Āöüé AA: Ambulatory care (A) ........................................................................................ 286 ðøąđõì AA01 Ambulatory care sensitive Ccondition (A) ........................................... 286 õćÙñîüÖ Ö. ĒîüìćÜÖćøÖĈĀîéøĀĆÿêĆüßĊĚüĆé THIP ..................................................................... 291 õćÙñîüÖ ×. ēÙøÜÿøšćÜ KPI template THIP ðŘÜïðøąöćè 2565 ............................................. 293 õćÙñîüÖ Ù. ךĂÖĈĀîéÖćøÝĆéđÖĘïךĂöĎúĒúąøą÷ąđüúćÖćøĂĂÖøć÷ÜćîêĆüßĊĚüĆé THIP ................. 294 õćÙñîüÖ Ü. ĒîüìćÜÖćø×ĂðúéúĘĂÙךĂöĎúĔîøąïï THIP îĂÖøĂïðÖêĉ .................................... 297 õćÙñîüÖ Ý. ÙèąÖøøöÖćøøąïïÿćøÿîđìýđðøĊ÷ïđìĊ÷ïüĆéøąéĆïÙčèõćóēøÜó÷ćïćú ................ 298 õćÙñîüÖ Þ. ĒîüìćÜÖćøîĈđÿîĂêĆüßĊĚüĆéđóČęĂïøøÝčĔîïĆâßĊêĆüßĊĚüĆé THIP .................................... 299 õćÙñîüÖ ß. ÙüćöĀöć÷ĒúąÖćøĒïŠÜøąéĆï×ĂÜĒñúÖéìĆï êĆüßĊĚüĆéÖúčŠö CG01 ............................ 301 272 286 286 291 293 294 297 298 299 301

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P vi

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P ĒîüìćÜÖćøÝĆéÖúčŠöđðøĊ÷ïđìĊ÷ï×ĂÜēøÜó÷ćïćúÿöćßĉÖ THIP ÙèąÖøøöÖćøøąïïÿćøÿîđìýđðøĊ÷ïđìĊ÷ïüĆéøąéĆïÙčèõćóēøÜó÷ćïćú (THIP) ĕéšöĊÖćøìïìüî ĒîüìćÜÖćøÝĆéÖúčŠöđìĊ÷ïđÙĊ÷Ü×ĂÜēøÜó÷ćïćúÿöćßĉÖ THIP1 ēé÷ ĒïŠÜđðŨî 4 ÖúčŠö éĆÜîĊĚ ÖúčŠöìĊę1 ēøÜó÷ćïćúõćÙøĆå - öĊÖćøđøĊ÷îÖćøÿĂî Ēúąêêĉ÷õĎöĉĕéšĒÖŠ 1.1 ēøÜó÷ćïćúēøÜđøĊ÷îĒóì÷ŤöĊÖćøđøĊ÷îÖćøÿĂîÙøïìčÖÿć×ć 1.2 ēøÜó÷ćïćúēøÜđøĊ÷îĒóì÷ŤöĊÖćøđøĊ÷îÖćøÿĂîïćÜÿć×ć 1.3 ēøÜó÷ćïćúýĎî÷ŤöĊÖćøđøĊ÷îÖćøÿĂîÙøïìčÖÿć×ć 1.4 ēøÜó÷ćïćúýĎî÷ŤöĊÖćøđøĊ÷îÖćøÿĂîïćÜÿć×ć 1.5 ēøÜó÷ćïćúøąéĆïêêĉ÷õĎöĉöĊÖćøđøĊ÷îÖćøÿĂîìčÖÿć×ć 1.6 ēøÜó÷ćïćúøąéĆïêêĉ÷õĎöĉöĊÖćøđøĊ÷îÖćøÿĂîïćÜÿć×ć 1) 1.7 ēøÜó÷ćïćúøąéĆïêêĉ÷õĎöĉĕöŠöĊÖćøđøĊ÷îÖćøÿĂî 1.8 ÿëćïĆîđÞóćąìćÜ öĊÖćøđøĊ÷îÖćøÿĂîïćÜÿć×ć 1.9 ÿëćïĆîđÞóćąìćÜ ĕöŠöĊÖćøđøĊ÷îÖćøÿĂî ÖúčŠöìĊę2 ēøÜó÷ćïćúõćÙøĆå - ìĆęüĕð ÖúčŠöìĊę3 ēøÜó÷ćïćúõćÙøĆå - ßčößî ÖúčŠöìĊę4 ēøÜó÷ćïćúđĂÖßî Āöć÷đĀêč: 1. ēøÜó÷ćïćúÖúčŠöÿëćïĆîĒóì÷ýćÿêøŤĀöć÷ëċÜ ēøÜó÷ćïćúìĊęöĊĀúĆÖÿĎêøĒóì÷ýćÿêøŤ ïĆèæĉêđðŨî×ĂÜêîđĂÜ 2. öĊÖćøđøĊ÷î-ÿĂîÙøïìčÖÿć×ć Āöć÷ëċÜ öĊÖćøđøĊ÷îÖćøÿĂîøąéĆï resident ÿć×ćĀúĆÖ Ùøï 5 ÿć×ć ĕéšĒÖŠ 1) ÿĎêĉîøĊđüßÖøøö 2) ýĆú÷Öøøö 3) Ăć÷čøÖøøö 4) ÖčöćøđüßÖøøö 5) ýĆú÷ÖøøöĂĂøŤ ēíðŗéĉÖÿŤ 3. ēøÜó÷ćïćúýĎî÷Ť/êêĉ÷õĎöĉĀöć÷ëċÜ ēøÜó÷ćïćúìĊęöĊÖćøøĆïÿŠÜêŠĂ (refer) ĔîĀúć÷ÿć×ć 4. ÿëćïĆîđÞóćąìćÜ Āöć÷ëċÜ ēøÜó÷ćïćúìĊęöĊÖćøøĆïÿŠÜêŠĂ (refer) ĔîïćÜÖúčŠöēøÙĀøČĂđÞóćąÿć×ć 1 ĂšćÜĂĉÜ øć÷ÜćîÖćøðøąßčöÙèąÖøøöÖćøøąïïÿćøÿîđìýđðø÷ïđì Ċ Ċ÷ïüĆéøąéĆïÙčèõćóēøÜó÷ćïćú ÙøĆĚÜìĊę 3 ðŘÜïðøąöćè 2562 üĆîìĊę 17 ÿĉÜĀćÙö 2562, ÿëćïĆîøĆïøĂÜÙčèõćóÿëćîó÷ćïćú (ĂÜÙŤÖćøöĀćßî) 1

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 2 øć÷ÖćøïĆâßêĊĆüßĊĚüĆéđðøĊ÷ïđìĊ÷ï ðŘÜïðøąöćè 2566 ÙèąÖøøöÖćøøąïïÿćøÿîđìýđðøĊ÷ïđìĊ÷ïüĆéøąéĆïÙčèõćóēøÜó÷ćïćú (THIP) ĕéšìïìüîøć÷Öćø êĆüßĊĚüĆéđðøĊ÷ïđìĊ÷ïēé÷óĉÝćøèćêćöĀúĆÖđÖèæŤĂÜÙŤðøąÖĂï 7 ךà éĆÜîĊĚ 1) êĆüßĊĚüĆéìĊęöĊÙüćöÿĈÙĆâêŠĂÙčèõćóĔîøąïï×ĂÜēøÜó÷ćïćú 2) êĆüßĊĚüĆéìĊęÿŠÜÿĆââćèßĆéđÝîđóČęĂÖćøđðøĊ÷ïđìĊ÷ï 3) ÿćöćøëĂšćÜĂĉÜĕéšìćÜüĉßćÖćø 4) öĊðøąē÷ßîŤêŠĂÖøąïüîÖćøóĆçîćÙčèõćó 5) öĊĂÜÙŤðøąÖĂïìĊęöĊÙčèÿöïĆêĉĔîøąéĆïìĊę÷ĂöøĆïĕéšÿĈĀøĆïÖćøêĆéÿĉîĔÝđßĉÜÖćøÝĆéÖćø 6) đðŨîĕðĕéšÝøĉÜ ĒúąÙčšöÙŠćĔîÖćøđÖĘïךĂöĎúĔĀšĕéšëĎÖêšĂÜ 7) ÙĈîċÜëċÜñúÖøąìïêŠĂñĎšêĆéÿĉîĔÝĒúąñĎšøĆïñĉéßĂïĔîÖćøðäĉïĆêĉÜćî ĔîðŘÜïðøąöćè 2565 ÙèąÖøøöÖćøĄ öĊÖćøìïìüîðøĆïðøčÜĒúąđóĉęöøć÷ÖćøêĆüßĊĚüĆéđðøĊ÷ïđìĊ÷ï êćö “ïĆâßĊêĆüßĊĚüĆéđðøĊ÷ïđìĊ÷ïøąïïÿćøÿîđìýđðøĊ÷ïđìĊ÷ïüĆéøąéĆïÙčèõćóēøÜó÷ćïćú ðŘÜïðøąöćè 2566” ÝĈîüî 232 øć÷Öćø (ÝćÖđéĉö 225 êĆüßĊĚüĆé) ēé÷ĒïŠÜÖúčŠöêĆüßĊĚüĆé đðŨî 5 ÖúčŠö éĆÜîĊĚ 1. ÖúčŠöêĆüßĊĚüĆéøć÷ēøÙ ÝĈîüî 110 êĆüßĊĚüĆé (đéĉööĊ117 êĆüßĊĚüĆé) 2. ÖúčŠöêĆüßĊĚüĆéÖøąïüîÖćøéĎĒúñĎšðśü÷ìÿĈÙ Ċę Ćâ ÝĈîüî 38 êĆüßĊĚüĆé (đéĉööĊ36 êĆüßĊĚüĆé) 3. ÖúčŠöêĆüßĊĚüĆéøąïïÜćîÿĈÙĆâ ÝĈîüî 57 êĆüßĊĚüĆé (đéĉööĊ 57 êĆüßĊĚüĆé) 4. ÖúčŠöêĆüßĊĚüĆéÿøšćÜđÿøĉöÿč×õćó ÝĈîüî 22 êĆüßĊĚüĆé (đéĉööĊ 8 êĆüßĊĚüĆé) 5. ÖúčŠöêĆüßĊĚüĆéÖúčŠöēøÙìĊęÙüøøĆÖþćĒïïñĎšðśü÷îĂÖ ÝĈîüî 5 êĆüßĊĚüĆé (đéĉööĊ5 êĆüßĊĚüĆé) øć÷úąđĂĊ÷é×ĂÜÖúčŠöêĆüßĊĚüĆéđðøĊ÷ïđìĊ÷ï ðøąÖĂïéšü÷ 1. ÖúčŠöêĆüßĊĚüĆéøć÷ēøÙ (Disease: D) ðøąÖĂïéšü÷ 10 Āöüé éĆÜîĊĚ 1.1 Āöüé DH: ēøÙĀúĂéđúČĂéĀĆüĔÝ (Cardiovascular disease) 1.2 Āöüé DN: ēøÙĀúĂéđúČĂéÿöĂÜ (Neurovascular disease) 1.3 Āöüé DR: ēøÙøąïïìćÜđéĉîĀć÷ĔÝ (Respiratory disease) 1.4 Āöüé DC: ēøÙđøČĚĂøĆÜ (Chronic disease) 1.5 Āöüé DO: ēøÙøąïïÖúšćöđîČĚĂĒúąÖøąéĎÖ (Musculoskeletal disease) 1.6 Āöüé DG: ēøÙøąïïìćÜđéĉîĂćĀćø (Gastrointestinal disease) 1.7 Āöüé DP: ēøÙđÖĊę÷üÖĆïđéĘÖ (Pediatric disease) 1.8 Āöüé DS: ēøÙđÖĊę÷üÖĆïñĎšêĉé÷ćĒúąÿćøđÿóêĉé (Substance use disorder) จำนวน 232 รายการ (จากเดมิ 225 ตวชัว้ีดั) จำนวน 110 ตวชัว้ีดั จำนวน 22 ตวชัว้ีดั

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 3 1.9 Āöüé DE: ýĎî÷ŤÙüćöđðŨîđúĉý (Center of excellence) 1.10 Āöüé DM: ÖúčŠöēøÙÿč×õćóÝĉê (Mental health) 2. ÖúčŠöêĆüßĊĚüĆéÖøąïüîÖćøéĎĒúñĎšðśü÷ìÿĈÙ Ċę Ćâ (Care process: C) ðøąÖĂïéšü÷ 7 Āöüé éĆÜîĊĚ 2.1 Āöüé CM: ÖćøéĎĒúöćøéćĒúąìćøÖ (Maternal and child health care) 2.2 Āöüé CA: ÖćøéĎĒúñĎšðśü÷ìćÜéšćîüĉÿĆââĊ(Anesthesia care) 2.3 Āöüé CO: ÖćøéĎĒúñĎšðśü÷ìćÜéšćîÖćøñŠćêĆé (Operative care) 2.4 Āöüé CG: ÖćøéĎĒúñĎšðśü÷ìĆęüĕð (General care) 2.5 Āöüé CE: ÖćøéĎĒúñĎšðśü÷ÞčÖđÞĉî (Emergency care) 2.6 Āöüé CI: ÖćøéĎĒúñĎšðśü÷üĉÖùêĉ (Intensive care) 2.7 Āöüé CP: ÖćøéĎĒúñĎšðśü÷ÿč×õćóÝĉê (Psychiatry care) 3. ÖúčŠöêĆüßĊĚüĆéøąïïÜćîÿĈÙĆâ (System: S) ðøąÖĂïéšü÷ 8 Āöüé éĆÜîĊĚ 3.1 Āöüé SI: øąïïÙüïÙčöĒúąðŜĂÜÖĆîÖćøêĉéđßČĚĂ(Infectious and prevention control system) 3.2 Āöüé SL: øąïïÖćøêøüÝüĉîĉÝÞĆ÷ìćÜĀšĂÜðäĉïĆêĉÖćø (Laboratory system 3.3 Āöüé SH: øąïïïøĉĀćøìøĆó÷ćÖøïčÙÙú (Human resource system) 3.4 Āöüé SF: øąïïïøĉĀćøÖćøđÜĉîÖćøÙúĆÜ (Financial system) 3.5 Āöüé SC: øąïïïøĉÖćøðøąßćßî (Customer service system) 3.6 Āöüé SG: øąïïĂõĉïćúĂÜÙŤÖø (Governance system) 3.7 Āöüé SS: øąïïÖćøìĈĔĀšðøćýÝćÖđßČĚĂ (Sterilization system) 3.8 Āöüé SM: øąïï÷ć (Medication system) 4. ÖúčŠöêĆüßĊĚüĆéÿøšćÜđÿøĉöÿč×õćó (Health promotion: H) ðøąÖĂïéšü÷ 5 Āöüé éĆÜîĊĚ 4.1 Āöüé HE: êĆüßĊĚüĆéÿøšćÜđÿøĉöÿč×õćóïčÙúćÖø (Employee health promotion) 4.2 Āöüé HC: êĆüßüĊĚĆéÿøšćÜđÿøĉöÿč×õćóêćöÖúčŠöïøĉÖćøúĎÖÙšć (Customer health promotion) 4.3 Āöüé HD: êĆüßĊĚüĆéÿøšćÜđÿøĉöÿč×õćóêćöÖúčŠöēøÙ (Disease-based health promotion) 4.4 Āöüé HP: êĆüßĊĚüĆéÿøšćÜđÿøĉöÿč×õćóêćöÖúčŠöüĆ÷ (Population-based health promotion) 4.5 Āöüé HH: êĆüßĊĚüĆéÿøšćÜđÿøĉöÿč×õćóêćöðŦÝÝĆ÷đÿĊę÷ÜõĆ÷ÿč×õćó (Health risk factors) 5. ÖúčŠöêĆüßĊĚüĆéÖúčŠöēøÙìĊęÙüøøĆÖþćĒïïñĎšðśü÷îĂÖ (Ambulatory care: A) ðøąÖĂïéšü÷1 Āöüé éĆÜîĊĚ 5.1 Āöüé AA: êĆüßĊĚüĆéÖúčŠöēøÙìĊęÙüøøĆÖþćĒïïñĎšðśü÷îĂÖ (ACSC: Ambulatory Care Sensitive Condition)

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P üĉíĊÖćøĔßšÜćîøĀĆÿêĆüßüĊĚĆéđðøĊ÷ïđìĊ÷ï THIP øĀĆÿêĆüßĊĚüĆé: ðøąÖĂïéšü÷ ßčéĂĆÖþø 2 êĆüĂĆÖþø ĒúąßčéêĆüđú×ĀúĆÖÿĉï ÝĈîüî 2 ßčéêĆüđú× (4 êĆüđú×) ēé÷öĊÙüćöĀöć÷ éĆÜîĊĚ êĆüĂĆÖþøêĆüìĊę1: Āöć÷ëċÜ ÖúčŠöêĆüßĊĚüĆé 2) D – ÷ŠĂöćÝćÖ Disease ÖúčŠöêĆüßĊĚüĆéøć÷ēøÙ 3) C – ÷ŠĂöćÝćÖ Care process ÖúčŠöêĆüßĊĚüĆéÖøąïüîÖćøéĎĒúñĎšðśü÷ìĊęÿĈÙĆâ 4) S – ÷ŠĂöćÝćÖ System ÖúčŠöêĆüßĊĚüĆéøąïïÜćîÿĈÙĆâ 5) H – ÷ŠĂöćÝćÖ Health promotion ÖúčŠöêĆüßĊĚüĆéÿøšćÜđÿøĉöÿč×õćó 6) A – ÷ŠĂöćÝćÖ Ambulatory care ÖúčŠöêĆüßĊĚüĆéÖúčŠöēøÙìĊęÙüøøĆÖþćĒïïñĎšðśü÷îĂÖ êĆüĂĆÖþøêĆüìĊę2: Āöć÷ëċÜ ĀöüéêĆüßĊĚüĆé ßčéêĆüđú×ĀúĆÖÿĉï (øĀĆÿêĆüđú× êĆüìĊę 1 - 2) ßčéìĊę1: Āöć÷ëċÜ ðøąđõìêĆüßĊĚüĆé ßčéêĆüđú×ĀúĆÖÿĉï (øĀĆÿêĆüđú× êĆüìĊę 3 - 4) ßčéìĊę2: Āöć÷ëċÜ úĈéĆïêĆüßĊĚüĆé êĆüĂ÷ŠćÜÖćøĔßšøĀĆÿêĆüßĊĚüĆé DN0101 Āöć÷ëċÜ êĆüßĊĚüĆéÖúčŠöēøÙ (Disease: D) ĔîĀöüéøąïïðøąÿćìĒúąĀúĂéđúČĂéÿöĂÜ (Neurovascular System: N) ðøąđõìêĆüßĊĚüĆéìĊę 01 ÙČĂ Stroke úĈéĆïêĆüßĊĚüĆéìĊę 01 ÙČĂ øć÷ÖćøêĆüßĊĚüĆé DN0101 øšĂ÷úąÖćøđÿĊ÷ßĊüĉê×ĂÜñĎšðśü÷ Stroke: Percent of mortality ÖúčŠöêĆüßĊĚüĆé ĀöüéêĆüßĊĚüĆé ðøąđõìêĆüßĊĚüĆé úĈéĆïêĆüßĊĚüĆé øć÷ÖćøêĆüßĊĚüĆé D N 01 01 DN0101 ÖúčŠöêĆüßĊĚüĆéøć÷ēøÙ ĀöüéêĆüßĊĚüĆé Neurovascular System ðøąđõìêĆüßĊĚüĆé Stroke úĈéĆïìĊę1 øšĂ÷úąÖćøđÿĊ÷ßĊüĉê×ĂÜñĎšðśü÷ Stroke Stroke: Percent of mortality 4

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P ĒñîñĆÜõćóøüö ÖúčŠöêĆüßĊĚüĆéøć÷ēøÙ (Disease: D) Āöüé ðøąđõì DH ēøÙĀúĂéđúČĂéĀĆüĔÝ (Cardiovascular disease) 01 Acute coronary syndrome 02 Coronary artery disease 03 Heart failure 04 Atrial fibrillation DN ēøÙĀúĂéđúČĂéÿöĂÜ (Neurovascular disease) 01 Stroke 02 Epilepsy 03 Head injury DR ēøÙøąïïìćÜđéĉîĀć÷ĔÝ (Respiratory disease) 01 Pneumonia 02 Tuberculosis 03 Asthma 04 COPD DC ēøÙđøČĚĂøĆÜ (Chronic disease) 01 Diabetes mellitus 02 Hypertension 03 HIV 04 Cancer 05 Chronic kidney disease DO ēøÙøąïïÖúšćöđîČĚĂĒúąÖøąéĎÖ (Musculoskeletal disease) 01 Femur 02 Hip arthroplasty 03 Knee arthroplasty DG ēøÙøąïïìćÜđéĉîĂćĀćø (Gastrointestinal disease) 01 Upper gatrointestinal hemorrhage 02 Appendicitis DP ēøÙđÖĊę÷üÖĆïđéĘÖ (Pediatric disease) 01 Diabetes in children and adolescents DS ēøÙđÖĊę÷üÖĆïñĎšêĉé÷ćĒúąÿćøđÿóêĉé (Substance use disorder) 01 Metamphetamine group 02 Alcohol group 03 Tobacco group 04 Opioid group 5

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 6 Āöüé ðøąđõì DE ýĎî÷ŤÙüćöđðŨîđúĉý (Center of Excellence) 01 Breast cancer 05 Stem cell transplantation 08 Thalassemia 12 Cleft lip – cleft palate and craniofacial disease 13 Infertility 14 Gastrointestinal scopy 16 Conductive and sensorineural hearing loss DM ÖúčŠöēøÙÿč×õćóÝĉê (Mental Health) 01 Global developmental delay (GDD) 02 Autism spectrum disorder (ASD) 03 Cerebral palsy 04 Children and adolescent psychiatry

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 7 øĀĆÿ ßČęĂêĆüßĊĚüĆé Āîšć 1. ïĆâßĊêĆüßĊĚüĆéøć÷ēøÙ (Disease: D) 1.1 Āöüé DH: Cardiovascular disease (Heart disease: H) 1.1.1 DH01 Acute coronary syndrome (ACS) øĀĆÿ ßČęĂêĆüßĊĚüĆé Āîšć DH0101 øšĂ÷úąÖćøđÿĊ÷ßĊüĉê×ĂÜñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî Acute coronary syndrome: Percent of mortality 39 DH0101.1 øšĂ÷úąÖćøđÿĊ÷ßĊüĉê×ĂÜñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ÷Ö×ċĚî (STEMI) Acute coronary syndrome (STEMI): Percent of mortality 40 DH0101.2 øšĂ÷úąÖćøđÿĊ÷ßĊüĉê×ĂÜñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ĕöŠ÷Ö×ċĚî (NSTE-ACS) Acute coronary syndrome (NSTE-ACSI): Percent of mortality 41 DH0102 øšĂ÷úąñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîìĊęĕéšøĆï÷ć Aspirin õć÷Ĕî 24 ßĆęüēöÜđöČęĂöćëċÜēøÜó÷ćïćú Acute coronary syndrome: Percent of patient receiving Aspirin within 24 hours of arrival 42 DH0103 øšĂ÷úąñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîìĊęĕéšøĆïÖćøÿĆęÜ÷ć Aspirin đöČęĂ ÝĈĀîŠć÷ĂĂÖÝćÖēøÜó÷ćïćú Acute coronary syndrome: Percent of Aspirin prescribed at discharge 43 DH0104 øšĂ÷úąñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîìĊęöĊLVSD ĒúąĕéšøĆï÷ć ACE inhibitors ĀøČĂ ARB Acute coronary syndrome: Percent of ACE inhibitors or ARB received for patient who have LVSD 44 DH0105 øšĂ÷úąñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîìĊęÿĎïïčĀøĊęĒúąĕéšøĆïÖćøĒîąîĈĔĀšÜé ïčĀøĊęøąĀüŠćÜÖćøĂ÷ĎŠēøÜó÷ćïćú Acute coronary syndrome: Percent of smoking cessation advice given 46 DH0106 øšĂ÷úąñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîìĊęĕéšøĆï÷ć Beta-blocker øąĀüŠćÜ øĆïĕüšøĆÖþćĔîēøÜó÷ćïćú Acute coronary syndrome: Percent of Beta-blocker receiving during hospital admitted 47

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 8 øĀĆÿ ßČęĂêĆüßĊĚüĆé Āîšć DH0107 øšĂ÷úąñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîìĊęĕéšøĆïÖćøÿĆęÜ÷ć Beta-blocker đöČęĂÝĈĀîŠć÷ÝćÖēøÜó÷ćïćú Acute coronary syndrome: Percent of Beta-blocker prescribed at discharge 48 DH0108 øą÷ąđüúćđÞúĊę÷ìĊęñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîìĕéĊę šøĆïÖćøìĈ EKG đöČęĂ öćëċÜēøÜó÷ćïćú Acute coronary syndrome: Average door to EKG time 49 DH0109 øą÷ąđüúćđÞúĊę÷ìĊęñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîöćëċÜēøÜó÷ćïćúÝî ĕéšøĆïÖćøÿŠÜêŠĂ Acute coronary syndrome: Average door to refer time 50 DH0110 øšĂ÷úąñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ÷Ö×ċĚî (STEMI) ìĊęĕéšøĆï Primary Percutaneous Coronary Intervention (PPCI) õć÷Ĕî 120 îćìĊĀøČĂ Fibrinolytic agent õć÷Ĕî 30 îćìĊđöČęĂĒøÖøĆï Acute coronary syndrome: Percent of Primary Percutaneous Coronary Intervention (PCI) given within 120 minutes or received Fibrinolytic agent within 30 minutes of arrival 51 DH0111 øšĂ÷úąÖćøøĆïÖúĆïđךćēøÜó÷ćïćú×ĂÜñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî õć÷Ĕî 28 üĆî ēé÷ĕöŠĕéšüćÜĒñî Acute coronary syndrome: Percent of unplanned re-admission within 28 days after last discharge 53 DH0112 øą÷ąđüúćüĆîîĂîđÞúĊę÷ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî Acute coronary syndrome: Average length of stay 54 DH0113 øšĂ÷úąñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ÷Ö×ċĚî (STEMI) ìĊęĕéšøĆï Fibrinolytic agent õć÷Ĕî 30 îćìĊđöČęĂöćëċÜēøÜó÷ćïćú Acute coronary syndrome: Percent of time to Fibrinolytic administration agents within 30 minutes of arrival 55 1.1.2 DH02 Coronary Artery Disease (CAD) DH0201 øšĂ÷úąÖćøđÿĊ÷ßĊüĉê×ĂÜñĎšðśü÷ìĊęìĈ Coronary Artery Bypass Graft (CABG) Coronary Artery Bypass Graft (CABG): Percent of mortality 57

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 9 øĀĆÿ ßČęĂêĆüßĊĚüĆé Āîšć DH0202 øšĂ÷úąÖćøĕéšøĆï÷ćðäĉßĊüîąĒïïðŜĂÜÖĆîĔîÖćøñŠćêĆé Coronary Artery Bypass Graft (CABG) Coronary Artery Bypass Graft (CABG): Percent of patient who received antibiotic prophylaxis 58 DH0203 øšĂ÷úąÖćøêĉéđßČĚĂĒñúñŠćêĆé Coronary Artery Bypass Graft (CABG) Coronary Artery Bypass Graft (CABG): Percent of surgical site Infection 59 DH0204 øšĂ÷úąÖćøđÿĊ÷ßĊüĉê×ĂÜñĎšðśü÷ìĊęìĈ CABG õć÷Ĕî 30 üĆîĀúĆÜøĆïÖćøøĆÖþćĒïï ñĎšðśü÷ĔîüĆîĒøÖ Coronary Artery Bypass Graft (CABG): percent of 30-days hospital mortality 60 1.1.3 DH03 Heart Failure (HF) DH0301 øšĂ÷úąñĎšðśü÷ĔîìĊęöĊĀĆüĔÝúšöđĀúüìĊęđðŨî Heart Failure Reduced Ejection Fraction (HFREF) ĕéšøĆï÷ć Angiotensin II Converting Enzyme inhibitors (ACEIs) ĀøČĂ Angiotensin II Receptor Blockers (ARBs) ĀøČĂ Mineralocorticoid Receptor Antagonists (MRA) Heart failure: Percent of patient with Heart Failure Reduced Ejection Fraction (HFREF) received Angiotensin II Converting Enzyme inhibitors (ACEIs) or Angiotensin II Receptor Blockers (ARBs) or Mineralocorticoid Receptor Antagonists (MRA) 61 DH0302 øšĂ÷úą×ĂÜñĎšðśü÷ìĊęöĊõćüąĀĆüĔÝúšöđĀúüìĊęÿĎïïčĀøĊęĕéšøĆïÖćøĒîąîĈĔĀšÜéïčĀøĊę øąĀüŠćÜÖćøĂ÷ĎŠēøÜó÷ćïćú Heart failure: Percent of smoking cessation advice given 63 1.1.4 DH04 Atrial fibrillation (AF) DH0401 øšĂ÷úą×ĂÜñĎšðśü÷ Atrial fibrillation ĕéšøĆï÷ć Warfarin öĊøąéĆï INR êćö đðŜćĀöć÷ÖćøøĆÖþć Atrial fibrillation: Percent of patient received Warfarin within target dose 64 DH0402 øšĂ÷úą×ĂÜÖćøđÖĉé Adverse event (major bleeding) ×ĂÜñĎšðśü÷ Atrial fibrillation ìĊęĕéšøĆï÷ć Warfarin Atrial Fibrillation: Percent of major bleeding (intracranial hemorrhage 66

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 10 øĀĆÿ ßČęĂêĆüßĊĚüĆé Āîšć and hemorrhage need blood transfusion) 1.2 Āöüé DN: Neurovascular Disease (N) 1.2.1 DN01 Stroke DN0101 øšĂ÷úąÖćøđÿĊ÷ßĊüĉê×ĂÜñĎšðśü÷ Stroke Stroke: Percent of mortality 67 DN0102 øšĂ÷úąñĎšðśü÷ēøÙÿöĂÜ×ćéđúČĂéìĊęĕéšøĆï÷ćêšćîđÖúĘéđúČĂé (antiplatelet) õć÷Ĕî 2 üĆî ĀúĆÜđךćøĆïÖćøøĆÖþćĔîēøÜó÷ćïćú Ischemic stroke: Percent of patient receiving Antiplatelet within 2 days of hospital admission 68 DN0103 øšĂ÷úąñĎšðśü÷ēøÙĀúĂéđúČĂéÿöĂÜ×ćéđúČĂéìĊęĕéšøĆïÖćøÿĆęÜ÷ćêšćîđÖúĘéđúČĂé (Antiplatelet) ĀøČĂ÷ćêšćîõćüąĒ×ĘÜêĆü×ĂÜđúČĂé (Anticoagulant) ×èą ÝĈĀîŠć÷ĂĂÖÝćÖēøÜó÷ćïćú Ischemic stroke: Percent of Antiplatelet or Anticoagulant therapy prescribed at discharge 69 DN0104 øšĂ÷úąñĎšðśü÷ēøÙĀúĂéđúČĂéÿöĂÜ×ćéđúČĂéìĊęöĊõćüąĀĆüĔÝĀšĂÜïîđêšîøąøĉÖĀøČĂ ĀĆüĔÝĀšĂÜïîđêšîøąøĆüĕéšøĆï÷ćêšćîõćüąĒ×ĘÜêĆü×ĂÜđúČĂé (Anticoagulant) Ischemic stroke: Percent of patient with Atrial fibrillation/Flutter receiving Anticoagulation therapy 70 DN0105 øšĂ÷úąñĎšðśü÷ēøÙĀúĂéđúČĂéÿöĂÜĕéšøĆïÙüćöøĎšĔî×èąĂ÷ĎŠìĊęēøÜó÷ćïćú Stroke: Percent of patients who were given stroke education during their hospital stay 71 DN0106 øšĂ÷úąñĎšðśü÷ēøÙĀúĂéđúČĂéÿöĂÜĕéšøĆïÖćøðøąđöĉîĒúąĕéšøĆïÖćøøĆÖþćéšćîđüß ýćÿêøŤôŚŪîôĎđóČęĂôŚŪîôĎÿöøøëõćó õć÷Ĕî 72 ßĆęüēöÜ Stroke: Percent of treatment, physiotherapy or rehabilitation in stroke or paralytic syndrome within 72 hours 72 DN0107 øšĂ÷úąÖćøøĆïÖúĆïđךćēøÜó÷ćïćú×ĂÜñĎšðśü÷ Stroke éšü÷ēøÙĀúĂéđúČĂéÿöĂÜ đéĉö õć÷Ĕî 28 üĆî ēé÷ĕöŠĕéšüćÜĒñî Stroke: Percent of unplanned re-admission of stroke within 28 days 73 DN0109 øą÷ąđüúćüĆîîĂîđÞúĊę÷×ĂÜñĎšðśü÷ Stroke Stroke: Average length of stay 74

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 11 øĀĆÿ ßČęĂêĆüßĊĚüĆé Āîšć DN0110 øšĂ÷úąñĎšðśü÷ Ischemic Stroke ìĊęĕéšøĆï Thrombolytic Agents õć÷Ĕî 60 îćìĊđöČęĂöćëċÜēøÜó÷ćïćú Ischemic Stroke: Percent of time to Thrombolytic administration agents within 60 minutes of arrival 75 1.2.2 Epilepsy: ÷ĆÜĕööŠ øć÷Öćøê Ċ ĆüßĊĚüĆéĔĀšđðøĊ÷ïđìĊ÷ï 1.2.3 DN03 Head Injury DN0301 øšĂ÷úąÖćøøĆïÖúĆïđךćēøÜó÷ćïćú×ĂÜñĎšðśü÷ìĊęìĈ Craniotomy ēé÷öĊÿćđĀêč ÝćÖÖćøïćéđÝĘïìĊęýĊøþą õć÷Ĕî 28 üĆî ēé÷ĕöŠĕéšüćÜĒñî Head Injury: Percent of unplanned re-admission of Craniotomy within 28 days 76 DN0302 øšĂ÷úą×ĂÜñĎšðśü÷ïćéđÝĘïìĊęýĊøþąìĊęđÿĊ÷ßĊüĉêõć÷Ĕî 48 ßĆęüēöÜ õć÷ĀúĆÜÖćø ïćéđÝĘï (đÞóćąñĎšðśü÷ïćéđÝĘïêŠĂÿöĂÜ) Head Injury: Percent of mortality within 48 hours 77 DN0303 øšĂ÷úąÖćøñŠćêĆéÿöĂÜĔîñĎšðśü÷ïćéđÝĘïìĊęýĊøþąìĊęöĊIntracranial Injury Head Injury: Percent of patient underwent craniotomy for Intracranial injury 78 1.3 Āöüé DR: Respiratory disease (R) 1.3.1 DR01 Pneumonia DR0101 øšĂ÷úąÖćøđÿĊ÷ßĊüĉêĀúĆÜÝćÖđךćøĆïÖćøøĆÖþć×ĂÜñĎšðśü÷ēøÙðĂéïüö Pneumonia: Percent of mortality after hospital admission 79 DR0102 øšĂ÷úąÖćøøĆïÖúĆïđךćēøÜó÷ćïćú×ĂÜñĎšðśü÷ēøÙðĂéïüöõć÷Ĕî 28 üĆîĀúĆÜ ēé÷ĕöŠĕéšüćÜĒñî Pneumonia: Percent of unplanned re-admission within 28 days after last discharge 80 DR0103 øšĂ÷úąñĎšðśü÷ēøÙðĂéïüöĕéšøĆïÙĈĒîąîĈĔĀšĂéĀøČĂđúĉÖïčĀøĊę øąĀüŠćÜĂ÷ĎŠĔî ēøÜó÷ćïćú Pneumonia: Percent of smoking cessation advice given 81 1.3.2 DR02 Mycobacterium Tuberculosis (TB) DR0201 øšĂ÷úąÖćøđÿĊ÷ßĊüĉê×ĂÜñĎšðśü÷üĆèēøÙðĂéĔîߊüÜ 12 đéČĂî 82

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 12 øĀĆÿ ßČęĂêĆüßĊĚüĆé Āîšć TB: Percent of mortality during 12 months DR0202 øšĂ÷úą×ĂÜñĎšêĉéđßČĚĂđĂßĕĂüĊĕéšøĆïÖćøÙĆéÖøĂÜüĆèēøÙðĂé TB: Percentage of people living with HIV having a TB screening 83 DR0203 øšĂ÷úąÙüćöÿĈđøĘÝÖćøøĆÖþćüĆèēøÙ TB: Percent of treatment success 84 DR0204 øšĂ÷úąñĎšðśü÷üĆèēøÙĕéšøĆïÖćøêøüÝÙĆéÖøĂÜ HIV TB: Percent of TB having a HIV screening 85 DR0205 øšĂ÷úąñĎšðśü÷üĆèēøÙìĊęöĊñúđúČĂéđĂßĕĂüĊïüÖĕéšøĆïÖćøøĆÖþćéšü÷ Antiretroviral therapy (ART) TB: Percent of HIV-positive TB patients started on Antiretroviral therapy (ART) 86 1.3.3 DR03 Asthma DR0301 øšĂ÷úąÖćøøĆïÖúĆïđךćēøÜó÷ćïćú×ĂÜñĎšðśü÷ Asthma õć÷Ĕî 28 üĆî ēé÷ĕöŠĕéš üćÜĒñî Asthma: Percent of unplanned re-admission within 28 days after last discharge 87 DR0302 øšĂ÷úąñĎšðśü÷ Asthma ĕéšøĆïÙĈĒîąîĈĔĀšĂéĀøČĂđúĉÖïčĀøĊę øąĀüŠćÜĂ÷ĎŠĔî ēøÜó÷ćïćú Asthma: Percent of smoking cessation advice given 88 1.3.4 DR04 COPD DR0401 øšĂ÷úąÖćøøĆïÖúĆïđךćēøÜó÷ćïćú×ĂÜñĎšðśü÷ COPD õć÷Ĕî 28 üĆî ēé÷ĕöŠĕéš üćÜĒñî COPD: Percent of unplanned re-admission into the hospital within 28 days after last discharge 89 DR0403 øšĂ÷úąÖćøđÿĊ÷ßĊüĉêÝćÖēøÙðĂéĂčéÖĆĚîđøČĚĂøĆÜ COPD: Percent of mortality 90 DR0404 øšĂ÷úą×ĂÜñĎšðśü÷ēøÙðĂéĂčéÖĆĚîđøČĚĂøĆÜìĊę÷ĆÜÿĎïïčĀøĊę COPD: Percent of patient with ongoing smoking 91 1.4 Āöüé DC: Chronic disease (C) 1.4.1 DC01 Diabetes mellitus (DM)

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 13 øĀĆÿ ßČęĂêĆüßĊĚüĆé Āîšć DC0103 øšĂ÷úą×ĂÜñĎšðśü÷đïćĀüćîĕéšøĆïÖćøÙĆéÖøĂÜđïćĀüćîđךćÝĂðøąÿćìêć DM: Percent of diabetic retinopathy screening 92 DC0107 øšĂ÷úąñĎšðśü÷đïćĀüćîĕéšøĆïÖćøêĆé×ćÝćÖõćüąĒìøÖàšĂî×ĂÜēøÙđïćĀüćî DM: Percent of lower-extremity amputation among patients with diabetes 93 DC0108 øšĂ÷úą×ĂÜñĎšðśü÷đïćĀüćîñĎšĔĀâŠìĊęÙüïÙčöøąéĆïîĚĈêćúĔîđúČĂéĕéšéĊ DM: Percent of good controlled of blood sugar in adult 94 DC0108.1 øšĂ÷úą×ĂÜñĎšðśü÷đïćĀüćîñĎšĔĀâŠĂć÷čđÖĉîÖüŠć 60 ðŘìĊęÙüïÙčöøąéĆïîĚĈêćúĔî đúČĂéĕéšéĊ DM: Percent of good controlled of blood sugar in adult aged œ 60 years old 95 DC0108.2 øšĂ÷úą×ĂÜñĎšðśü÷đïćĀüćîñĎšĔĀâŠìĊęĂć÷čêęĈÖüŠć 60 ðŘìĊęÙüïÙčöøąéĆïîĚĈêćúĔî đúČĂéĕéšéĊ DM: Percent of good controlled of blood sugar in adult aged < 60 years old 96 1.4.2 DC02 Hypertension (HT) DC0201 øšĂ÷úąñĎšðśü÷ÙüćöéĆîēúĀĉêÿĎÜìĊęÙüïÙčöÙüćöéĆîēúĀĉêĕéšéĊ HT: Percent of good controlled of blood pressure 97 DC0201.1 øšĂ÷úąñĎšðśü÷ÙüćöéĆîēúĀĉêÿĎÜĂć÷čîšĂ÷ÖüŠć 65 ðŘìĊęÙüïÙčöÙüćöéĆîēúĀĉêĕéšéĊ HT: Percent of good controlled of blood pressure of patient aged < 65 years old 98 DC0201.2 øšĂ÷úą×ĂÜñĎšðśü÷ÙüćöéĆîēúĀĉêÿĎÜĂć÷čđÖĉîÖüŠć 65 ðŘìĊęÙüïÙčöÙüćöéĆîēúĀĉê ĕéšéĊ HT: Percent of good controlled of blood pressure of patient aged œ 65 years old 99 1.4.3 DC03 HIV DC0301 øšĂ÷úą×ĂÜñĎšêĉéđßČĚĂđĂßĕĂüĊìĊęÖĉî÷ćêšćîĕüøĆÿ ĕéšøĆïÖćøêøüÝ Viral load (VL) Ă÷ŠćÜîšĂ÷ 1 ÙøĆĚÜêŠĂðŘ HIV: Percent of people living with HIV with at least one test viral load (VL) after ARV treatment 10 99 100 101

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 14 øĀĆÿ ßČęĂêĆüßĊĚüĆé Āîšć DC0302 øšĂ÷úą×ĂÜñĎšêĉéđßČĚĂđĂßĕĂüĊìĊęöĊViral load (VL) < 50 copies/ml ĀúĆÜÝćÖÖĉî ÷ćêšćîĕüøĆÿöćĒúšü 12 đéČĂî HIV: Percent of people living with HIV with viral load (VL) < 50 copies/ml after ARV treatment 12 months ago 101 DC0306 øšĂ÷úą×ĂÜñĎšêĉéđßČĚĂđĂßĕĂüĊđóýĀâĉÜĕéšøĆïÖćøÙĆéÖøĂÜöąđøĘÜðćÖöéúĎÖ HIV: Percent of people living with HIV screening PAP smear 102 DC0307 øšĂ÷úą×ĂÜñĎšêĉéđßČĚĂđĂßĕĂüĊøć÷ĔĀöŠìĊęĕéšøĆïÖćøêøüÝÙĆéÖøĂÜēøÙàĉôŗúĉÿ HIV: Percent of people living with HIV newly registered who were tested for syphilis 103 DC0308 øšĂ÷úą×ĂÜñĎšêĉéđßČĚĂđĂßĕĂüĊ/đĂéÿŤìĊęĕéšøĆïÖćøøĆÖþćéšü÷÷ćêšćîĕüøĆÿ è ðŦÝÝčïĆî HIV: Percent of people living with HIV who were currently receiving antiretroviral therapy 104 DC0309 øšĂ÷úą×ĂÜñĎšêĉéđßČĚĂđĂßĕĂüĊøć÷ĔĀöŠìĊęöĊךĂïŠÜßĊĚĔîÖćøøĆï÷ćðŜĂÜÖĆîüĆèēøÙ (Tuberculosis preventive therapy: TPT) ĕéšøĆï÷ć TPT HIV: Percent of newly diagnosed people living with HIV were receiving tuberculosis preventive therapy 105 1.4.4 DC04 Cancer DC0401 øšĂ÷úąÖćøđÿĊ÷ßĊüĉê×ĂÜñĎšðśü÷ēøÙöąđøĘÜ Cancer: Percent of mortality 106 DC0402 øšĂ÷úąÖćøøĆïÖúĆïđךćēøÜó÷ćïćúÖŠĂîüĆîîĆéēé÷ĕöŠĕéšüćÜĒñî×ĂÜñĎšðśü÷öąđøĘÜ Cancer: Percent of unplanned re-admission 107 DC0403 øšĂ÷úąÖćøđÿĊ÷ßĊüĉêéšü÷ēøÙöąđøĘÜêĆï Liver Cancer: Percent of mortality 108 1.4.5 DC05 Chronic kidney disease (CKD) DC0501 øšĂ÷úą×ĂÜñĎšðśü÷ēøÙĕêđøČĚĂøĆÜìĊęÿćöćøëßąúĂÙüćöđÿČęĂö×ĂÜĕêĕéšêćöđðŜćĀöć÷ CKD: Percent of patients who achieve the kidney function deterioration delayed target 109 DC0502 øšĂ÷úą×ĂÜñĎšðśü÷ēøÙĕêđøČĚĂøĆÜìĊęĕéšøĆï÷ć ACEIs ĀøČĂ ARBs CKD: Percent of patients who are receiving ACEIs or ARBs 111 1.5 Āöüé DO: Musculoskeletal disease (O) 102 103 104 105 106 107 108 109 110 112

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 15 øĀĆÿ ßČęĂêĆüßĊĚüĆé Āîšć 1.5.1 DO01 Femur: ÷ĆÜĕöŠöĊøć÷ÖćøêĆüßĊĚüĆéĔĀšđðøĊ÷ïđìĊ÷ï 1.5.2 DO02 Hip DO0202 øšĂ÷úą×ĂÜñĎšðśü÷ñŠćêĆéđðúĊę÷îךĂÿąēóÖ ĕéšøĆï Prophylactic antibiotic Hip arthroplasty: Percent of patients who received antibiotic prophylaxis in Hip arthroplasty 113 DO0204 øšĂ÷úąÖćøêĉéđßČĚĂĒñúñŠćêĆéđðúĊę÷îךĂÿąēóÖõć÷Ĕî 1 ðŘ Hip arthroplasty: Percent of hip arthroplasty associated infection within 1 Year 114 DO0205 øšĂ÷úąÖćøêĉéđßČĚĂĒñúñŠćêĆéđðúĊę÷îךĂÿąēóÖõć÷Ĕî 90 üĆî Hip arthroplasty: Percent of hip arthroplasty associated infection within 90 days 115 1.5.3 DO03 Knee DO0302 øšĂ÷úą×ĂÜñĎšðśü÷ñŠćêĆéđðúĊę÷îךĂđ׊ć ĕéšøĆï Prophylactic Antibiotic Knee Arthroplasty: Percent of patients who received antibiotic prophylaxis 116 DO0303 øšĂ÷úąÖćøêĉéđßČĚĂĔîךĂđ׊ćĀúĆÜÖćøñŠćêĆéđðúĊę÷îךĂđ׊ćõć÷Ĕî 1 ðŘ Knee Arthroplasty: Percent of surgical infection within 1 year 117 DO0304 øšĂ÷úąÖćøêĉéđßČĚĂĔîךĂđ׊ćĀúĆÜÖćøñŠćêĆéđðúĊę÷îךĂđ׊ćõć÷Ĕî 90 üĆî Knee Arthroplasty: Percent of surgical infection within 90 days 118 1.6 Āöüé DG: Gastrointestinal disease (G) 1.6.1 DG01 Upper GI Hemorrhage (UGIH) DG0101 øšĂ÷úąÖćøøĆïÖúĆïđךćēøÜó÷ćïćú×ĂÜñĎšðśü÷ Upper GI Hemorrhage õć÷Ĕî 28 üĆî ēé÷ĕöŠĕéšüćÜĒñî Upper Gastrointestinal Hemorrhage (UGIH): Percent of unplanned re-admission into the hospital within 28 days after last discharge 119 DG0102 øą÷ąđüúćüĆîîĂîđÞúĊę÷ñĎšðśü÷ Upper GI Hemorrhage (UGIH) Upper Gastrointestinal Hemorrhage (UGIH): Average length of stay 120 1.6.2 DG02 Appendicitis DG0201 øšĂ÷úąÖćøđÖĉéĕÿšêĉęÜìąúčĔîñĎšðśü÷ēøÙĕÿšêĉęÜĂĆÖđÿï Acute Appendicitis: Percent of abruption 121 114 115 116 117 118 119 120 121 122

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 16 øĀĆÿ ßČęĂêĆüßĊĚüĆé Āîšć DG0202 øšĂ÷úąÖćøđÿĊ÷ßĊüĉêÝćÖĕÿšêĉęÜĂĆÖđÿï Acute Appendicitis: Percent of mortality 122 1.7 Āöüé DP: Pediatric Disease (P) 1.7.1 DP: Diabetes in child and adolescent (DP) DP0101 øšĂ÷úą×ĂÜñĎšðśü÷đïćĀüćîßîĉéìĊę1 ĔîđéĘÖĒúąüĆ÷øčŠîĂć÷čîšĂ÷ÖüŠć 18 ðŘìĊę ÙüïÙčöøąéĆïîĚĈêćúĕéšéĊ Diabetes in child and adolescent: Percent of good controlled of blood sugar (age < 18 years) 123 1.8 Āöüé DS: Substance Use Disorder (S) 1.8.1 DS01 Methamphetamine Group DS0101 øšĂ÷úą×ĂÜñĎšêĉé÷ćđÿóêĉéÖúčŠö Methamphetamine ēé÷øüöìĊęĀ÷čéđÿó êŠĂđîČęĂÜ 3 đéČĂî Methamphetamine Group: 3 months total remission rate 125 1.8.2 DS02 Alcohol Group DS0201 øšĂ÷úą×ĂÜñĎšêĉéÿčøćēé÷øüö ìĊęĀ÷čéđÿóêŠĂđîČęĂÜ 3 đéČĂî Alcohol Group: 3 months total remission rate 126 1.8.3 DS03 Tobacco Group DS0301 øšĂ÷úą×ĂÜñĎšêĉé÷ćÿĎïēé÷øüö ìĊęĀ÷čéđÿóêŠĂđîČęĂÜ 3 đéČĂî Tobacco Group: 3 months total remission rate 127 1.8.4 DS04 Opioid Group DS0401 ĂĆêøćÙÜĂ÷ĎŠĔîÖćøïĈïĆéøĆÖþć 1 ðŘéšü÷đöìćēéîøą÷ą÷ćü×ĂÜñĎšêĉéÿćøđÿóêĉéĔî ÖúčŠö Opioid Opioid Group: 1 year retention rate of opioid in methadone maintenance program 128 1.9 Āöüé DE: Center of excellence (E) 1.9.1 DE01 Breast cancer DE0101 øą÷ąđüúćÖćøøĂêøüÝõć÷ĀúĆÜÖćøÿŠÜðøċÖþć×ĂÜñĎšðśü÷ìĊęöĊñúđööēöĒÖøöêĆĚÜĒêŠ BI-RADS 4 ×ċĚîĕð Breast Cancer: Consultation time in patient with BIRADS 4 or greater mammography result 129 123 124 126 127 128 129 130

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 17 øĀĆÿ ßČęĂêĆüßĊĚüĆé Āîšć DE0103 øšĂ÷úąÖćøêøüÝóïñĎšðśü÷öąđøĘÜđêšćîöøą÷ąĒøÖ Stage 1, 2 Breast Cancer: Percent of early diagnosis of stage 1, 2 130 1.9.2 DE02 Laryngeal cancer 1.9.3 DE03 Thyroid cancer 1.9.4 DE04 Colon cancer 1.9.5 DE05 Stem cell transplantation DE0501 ĂĆêøćÖćøðúĎÖëŠć÷êĉé (Engraftment) ×ĂÜñĎšðśü÷ Stem cell tranplantation õć÷Ĕî 45 üĆî ĀúĆÜÖćøðúĎÖëŠć÷ĕ×ÖøąéĎÖ Stem Cell Transplantation: Engraftment rate within 45 days 131 1.9.6 DE06 Leukemia 1.9.7 DE07 Hemophilia 1.9.8 DE08 Thallassemia DE0801 øšĂ÷úą×ĂÜñĎšðśü÷ Transfusion Dependent Thalassemia (TDT) ìĊęĂć÷č öćÖÖüŠć 2 ðŘĒúąëċÜ 15 ðŘöĊõćüąíćêčđĀúĘÖđÖĉî (Serum ferritin > 1000 ug/L) ìĊęĕéšøĆï÷ć×ĆïíćêčđĀúĘÖ TDT in Pediatrics Patient: Percent of received iron chelator in patient with iron overload (serum ferrous > 1000 ug/L) 132 1.9.9 DE09 Kidney transplant 1.9.10 DE10 Liver transplant 1.9.11 DE11 Trauma (severe head injury) 1.9.12 DE12 Cleft lip – Cleft palate and craniofacial disease DE1201 øšĂ÷úąñĎšðśü÷ìĊęđךćøĆïÖćøñŠćêĆéàŠĂöĒàöðćÖĒĀüŠÜêćöđÖèæŤßŠüÜĂć÷čĕöŠđÖĉî 6 đéČĂî Cleft Lip: Percent of patients who had cleft lip repair with under 6 months of age 133 DE1202 øšĂ÷úąñĎšðśü÷ìĊęđךćøĆïÖćøñŠćêĆéàŠĂöĒàöđóéćîēĀüŠêćöߊüÜĂć÷čĕöŠđÖĉî 18 đéČĂî Cleft Palate: Percent of patients who had cleft Palate repair with under 18 months of age 134 1.9.13 DE13 Infertility 131 132 133 134 135

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 18 øĀĆÿ ßČęĂêĆüßĊĚüĆé Āîšć DE1301 ĂĆêøćÖćøêĆĚÜÙøøõŤêŠĂøĂïÖćøĔÿŠêĆüĂŠĂî×ĂÜñĎšøĆïïøĉÖćøìĈđéĘÖĀúĂéĒÖšüĒúą ÷šć÷êĆüĂŠĂîøĂïÿé (ÖúčŠöĂć÷čîšĂ÷ÖüŠć 34 ðŘ) Infertility: Clinical pregnancy rate per Embryo Transfer following IVF/ICSI and Fresh embryo transfer (age < 34 years) 135 DE1302 ĂĆêøćÖćøêĆĚÜÙøøõŤêŠĂøĂïÖćøĔÿŠêĆüĂŠĂî×ĂÜñĎšøĆïïøĉÖćøìĈđéĘÖĀúĂéĒÖšüĒúą ÷šć÷êĆüĂŠĂîøĂïÿé (ÖúčŠöĂć÷ 34 - 39 č ðŘ) Infertility: Clinical pregnancy rate per embryo transfer following IVF/ICSI and fresh embryo transfer (age 34 - 39 Years) 136 DE1303 ĂĆêøćÖćøêĆĚÜÙøøõŤêŠĂøĂïÖćøĔÿŠêĆüĂŠĂî×ĂÜñĎšøĆïïøĉÖćøìĈđéĘÖĀúĂéĒÖšüĒúą ÷šć÷êĆüĂŠĂîøĂïÿé (ÖúčŠöĂć÷ 40 č ðŘ×ċĚîĕð) Infertility: Clinical pregnancy rate per embryo transfer following IVF/ICSI and fresh embryo transfer (age > 40 years) 137 DE1304 ĂĆêøćÖćøêĆĚÜÙøøõŤêŠĂøĂïÖćøĔÿŠêĆüĂŠĂî×ĂÜñĎšøĆïïøĉÖćøìĈđéĘÖĀúĂéĒÖšüĒúą ÷šć÷êĆüĂŠĂîøĂïĒߊĒ×ĘÜ (ÖúčŠöĂć÷čîšĂ÷ÖüŠć 34 ðŘ) Infertility: Clinical pregnancy rate per embryo transfer following IVF/ICSI and frozen embryo transfer (age < 34 years) 138 DE1305 ĂĆêøćÖćøêĆĚÜÙøøõŤêŠĂøĂïÖćøĔÿŠêĆüĂŠĂî×ĂÜñĎšøĆïïøĉÖćøìĈđéĘÖĀúĂéĒÖšüĒúą ÷šć÷êĆüĂŠĂîøĂïĒߊĒ×ĘÜ (ÖúčŠöĂć÷č 34 - 39 ðŘ) Infertility: Clinical pregnancy rate per embryo transfer following IVF/ICSI and frozen embryo transfer (age 34 - 39 years) 139 DE1306 ĂĆêøćÖćøêĆĚÜÙøøõŤêŠĂøĂïÖćøĔÿŠêĆüĂŠĂî×ĂÜñĎšøĆïïøĉÖćøìĈđéĘÖĀúĂéĒÖšüĒúą ÷šć÷êĆüĂŠĂîøĂïĒߊĒ×ĘÜ (ÖúčŠöĂć÷č 40 ðŘ×ċĚîĕð) Infertility: Clinical pregnancy rate per embryo transfer following IVF/ICSI and frozen embryo transfer (age > 40 years) 140 1.9.14 DE14 Gastrointestinal Scopy DE1401 øšĂ÷úąñĎšðśü÷ Upper GI Hemorrhage (UGIH) ĕéšøĆïÖćøÿŠĂÜÖúšĂÜõć÷Ĕî 24 ßĆęüēöÜ Upper Gastrointestinal Hemorrhage (UGIH): Percent of patients who had underwent EGD within 24 hours 141 DE1402 øšĂ÷úąñĎšðśü÷ Upper GI Hemorrhage (UGIH) ÖúčŠö High Risk ĕéšøĆïÖćøÿŠĂÜ ÖúšĂÜìćÜđéĉîĂćĀćøÿŠüîêšî õć÷Ĕî 24 ßĆęüēöÜ 142 136 137 138 139 140 141 142 143

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 19 øĀĆÿ ßČęĂêĆüßĊĚüĆé Āîšć Upper Gastrointestinal Hemorrhage (UGIH): Percent of high risk patients who had underwent EGD within 24 hours DE1403 øšĂ÷úąñĎšðśü÷ Non-variceal UGIH ÿćöćøëĀ÷čéđúČĂééšü÷üĉíĊÖćøÿŠĂÜÖúšĂÜĕéš ÿĈđøĘÝ Non-variceal Upper Gastrointestinal Hemorrhage (UGIH): Percent of hemostatic success by endoscopic approach 144 DE1404 øšĂ÷úąñĎšðśü÷ìĊęđÖĉéõćüąđúČĂéĂĂÖàĚĈÝćÖĒñúĔîøąïïìćÜđéĉîĂćĀćøÿŠüîêšî õć÷ĀúĆÜÝćÖÖćøĀ÷čéđúČĂééšü÷ÖćøÿŠĂÜÖúšĂÜ Upper Gastrointestinal Hemorrhage (UGIH): Recurrent rates of UGIH after upper endoscopic treatment 146 DE1405 ĂĆêøćÖćøđÖĉéõćüąĒìøÖàšĂîÝćÖÖćøÿŠĂÜÖúšĂÜìćÜđéĉîĂćĀćøÿŠüîêšîđóČęĂøĆÖþć UGIH Upper Gastrointestinal Hemorrhage (UGIH): Complication rates of upper endoscopic treatment 148 1.9.15 DE15 End of life care 1.9.16 DE16 Conductive and sensorineural hearing loss DE1601 øšĂ÷úą×ĂÜìćøÖĒøÖđÖĉéìĊęĕéšøĆïÖćøêøüÝÙĆéÖøĂÜÖćøĕéš÷ĉî õć÷Ĕî 30 üĆî New born: Percent of hearing screening within 30 days 149 1.10 Āöüé DM: Mental Health (M) 1.10.1 DM01 Global developmental delay (GDD) DM0101 øšĂ÷úąđéĘÖóĆçîćÖćøúŠćßšćøĂïéšćî (Global development delay: GDD) öĊóĆçîćÖćøéĊ×ċĚî GDD: Percent of children with global development delay that improved after intervented 150 DM0102 øšĂ÷úąđéĘÖóĆçîćÖćøúŠćßšćøĂïéšćî (Global development delay: GDD) öĊóĆçîćÖćøéĊ×ċĚî ÝćÖÖćøðøąđöĉîēé÷ĔßšđÙøČęĂÜöČĂ TEDA4I GDD: Percent of children with Global development delay that improved after intervented with TEDA4I 151 DM0103 øšĂ÷úąđéĘÖóĆçîćÖćøúŠćßšćøĂïéšćî (Global development delay: GDD) ÙÜĂ÷ĎŠĔîøąïïÖćøýċÖþćĕéšĂ÷ŠćÜîšĂ÷ 1 ðŘ 152 145 147 149 150 151 152 153

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 20 øĀĆÿ ßČęĂêĆüßĊĚüĆé Āîšć GDD: Percent of children with global developmentd delay that are included in educational system for at least 1 year 1.10.2 DM02 Autism spectrum disease (ASD) DM0201 øšĂ÷úąđéĘÖĂĂìĉÿêĉÖöĊóĆçîćÖćøéšćîõćþćĒúąÿĆÜÙöéĊ×ċĚî ASD: Percent of children with autism spectrum disorder (ASD) with social and communication skills improvement 153 DM0202 øšĂ÷úąđéĘÖĂĂìĉÿêĉÖöĊóĆçîćÖćøéšćîõćþćĒúąÿĆÜÙöéĊ×ċĚî ÝćÖÖćøðøąđöĉîēé÷ ĔßšđÙøČęĂÜöČĂ TEDA4I ASD: Percent of children with autism spectrum disorder (ASD) with social and communication skills improvement with TEDA4I 154 DM0203 øšĂ÷úąđéĘÖĂĂìĉÿêĉÖÙÜĂ÷ĎŠĔîøąïïÖćøýċÖþćĕéšĂ÷ŠćÜîšĂ÷ 1 ðŘ ASD: Percent of children with autism spectrum disorder (ASD) that are included in educational system for at least 1 year 155 1.10.3 DM03 Cerebral palsy DM0301 øšĂ÷úąñĎšðśü÷đéĘÖÿöĂÜóĉÖćø (Cerebral palsy) öĊóĆçîćÖćøéĊ×ċĚî Cerebral Palsy: Percent of children with cerebral palsy that improved after intervented 156 DM0302 øšĂ÷úąñĎšðśü÷đéĘÖÿöĂÜóĉÖćø (Cerebral palsy) öĊóĆçîćÖćøéĊ×ċĚî ÝćÖÖćø ðøąđöĉîēé÷ĔßšđÙøČęĂÜöČĂ TEDA4I Cerebral Palsy: Percent of children with cerebral palsy that improved after intervented 157 1.10.4 DM04 Child and adolescent psychiatry DM0401 øšĂ÷úąñĎšðśü÷đéĘÖÿöćíĉÿĆĚîøć÷ĔĀöŠĂćÖćøéĊ×ċĚîõć÷Ĕî 6 đéČĂî Child and adolescent psychiatry: Percent of children with AttentionDeficit Hyperactivity Disorder (ADHD) improved after intervented for 6 months 158 DM0402 øšĂ÷úąñĎšðśü÷đéĘÖàċöđýøšćĂćÖćøéĊ×ċĚîõć÷Ĕî 6 đéČĂî Child and adolescent psychiatry: Percent of children and adolescents with Major Depressive Disorder (MDD) improved after intervented for 6 months 159 154 155 156 157 158 159 160

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 21 ĒñîñĆÜõćóøüö ÖúčŠöêĆüßĊĚüĆéÖøąïüîÖćøéĒúñ Ď Ďšðśü÷ìĊęÿĈÙĆâ (Care process: C) Āöüé ðøąđõì CM ÖćøéĎĒúöćøéćĒúąìćøÖ (Maternal and Child health care) 01 Maternal Health Care Process 02 Child Health Care Process CA ÖćøéĎĒúñĎšðśü÷ìćÜéšćîüĉÿĆââĊ (Anesthesia care) 01 Anesthesia Care Process CO ÖćøéĎĒúñĎšðśü÷ìćÜéšćîÖćøñŠćêĆé (Operative care) 01 Operative Care Process CG ÖćøéĎĒúñĎšðśü÷ìĆęüĕð (General care) 01 Pressure Ulcer Care Process CE ÖćøéĎĒúñĎšðśü÷ÞčÖđÞĉî (Emergency care) 01 ER Care Process CI ÖćøéĎĒúñĎšðśü÷üĉÖùêĉ (Intensive care) 01 Sepsis Care Process CP ÖćøéĎĒúñĎšðśü÷Ýĉêđüß (Psychiatric care) 01 Child and Adolescent Psychiatry 02 Pediatric Neurodevelopmental Disorder

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 22 øĀĆÿ ßČęĂêĆüßĊĚüĆé Āîšć 2. ïĆâßĊêĆüßĊĚüĆéÖøąïüîÖćøéĎĒúñĎšðśü÷ìĊęÿĈÙâĆ (Care process: C) 2.1 Āöüé CM: Maternal and child health care process (M) 2.1.1 CM01 Maternal health care process CM0101 ÿĆéÿŠüîÖćøêć÷×ĂÜöćøéćÝćÖÖćøêĆĚÜÙøøõŤĒúą/ĀøČĂÖćøÙúĂé (êŠĂĒÿîìćøÖ đÖĉéöĊßĊó) Maternal: Mortality rate of mother from pregnancy and/or labour (1:100,000) 160 CM0104 øšĂ÷úąÖćøøĆïÖúĆïđךćēøÜó÷ćïćú×ĂÜñĎšÙúĂé Caesarean section õć÷Ĕî 28üĆî ēé÷ĕöŠĕéšüćÜĒñî Maternal: Percent of unplanned re-admission of caesarean section within 28 days 162 CM0105 øą÷ąđüúćüĆîîĂîđÞúĊę÷×ĂÜñĎšÙúĂéēé÷ÖćøñŠćêĆéÙúĂéìćÜĀîšćìšĂÜ Maternal: Average length of stay of caesarean section 163 CM0107 øšĂ÷úąÖćøêÖđúČĂéĀúĆÜÙúĂéđÞĊ÷ïóúĆîÖøèĊÙúĂéìćÜߊĂÜÙúĂé Maternal: Percent of immediate postpartum hemorrhage (Vaginal delivery) 164 CM0109 øšĂ÷úąÖćøßĆÖ×èąêĆĚÜÙøøõŤÙúĂéĀøČĂĀúĆÜÙúĂé Maternal: Percent of eclampsia in pregnancy induce Hypertension 165 CM0110 ĂĆêøćĀâĉÜêĆĚÜÙøøõŤìĊęöĊõćüąđïćĀüćî Maternal: Percent of gestational DM 166 CM0116 øšĂ÷úąÖćøĕéšøĆï Prophylactic antibiotic ĔîÖćøñŠćêĆé Abdominal hysterectomy Maternal: Percent of patients who received antibiotic prophylaxis in abdominal hysterectomy 167 CM0117 øšĂ÷úąÖćøêĉéđßČĚĂĒñúñŠćêĆé Abdominal hysterectomy Maternal: Percent of abdominal hysterectomy associated infection 168 CM0118 øšĂ÷úąÖćøñŠćêĆéÙúĂéïčêøðåöõĎöĉ×ĂÜēøÜó÷ćïćú Maternal: Percent of primary cesarean section 169 CM0119 øšĂ÷úąÖćøñŠćêĆéÙúĂéïčêøìĆĚÜĀöé×ĂÜēøÜó÷ćïćú 170 161 163 164 165 166 167 168 169 170 171

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 23 øĀĆÿ ßČęĂêĆüßĊĚüĆé Āîšć Maternal: Percent of overall cesarean section 2.1.2 CM02 Child health care process øĀĆÿ ßČęĂêĆüßĊĚüĆé Āîšć CM0201 ĂĆêøćÖćøêć÷ðøĉÖĈđîĉé (Ăć÷čÙøøõŤêĆĚÜĒêŠ24 ÿĆðéćĀŤ) Child: Perinatal mortality rate (24 weeks) 171 CM0202 ĂĆêøćÖćøêć÷ðøĉÖĈđîĉé (Ăć÷čÙøøõŤêĆĚÜĒêŠ28 ÿĆðéćĀŤ) Child: Perinatal mortality rate (28 weeks) 172 CM0203 ĂĆêøćÖćøêć÷×ĂÜìćøÖĒøÖđÖĉé Child: Neonatal mortality rate 173 CM0204 ĂĆêøćÖćø×ćéĂĂÖàĉđÝîĔîìćøÖĒøÖđÖĉé Child: Birth asphyxia rate 174 CM0205 ĂĆêøćÖćø×ćéĂĂÖàĉđÝîøčîĒøÜĔîìćøÖĒøÖđÖĉé Child: Severe birth asphyxia rate 175 CM0206 øšĂ÷úąìćøÖĒøÖđÖĉéîĚĈĀîĆÖêęĈÖüŠć 2,500 ÖøĆö Child: Percent of low birth weight < 2500 grams 176 CM0207 øšĂ÷úąÖćøđÿĊ÷ßĊüĉêĔîēøÜó÷ćïćú×ĂÜìćøÖĒøÖđÖĉéîĚĈĀîĆÖêęĈÖüŠć 1,000 ÖøĆö õć÷Ĕî 28üĆî Child: Percent of neonatal mortality with birth weight < 1,000 grams within 28 days 177 CM0208 øšĂ÷úąÖćøđÿĊ÷ßĊüĉêĔîēøÜó÷ćïćú×ĂÜìćøÖĒøÖđÖĉéîĚĈĀîĆÖ 1,000-1,499 ÖøĆö õć÷Ĕî 28 üĆî Child: Percent of neonatal mortality with birth weight between 1,000 - 1,499 grams within 28 days 178 CM0209 øšĂ÷úąÖćøđÿĊ÷ßĊüĉêĔîēøÜó÷ćïćú×ĂÜìćøÖĒøÖđÖĉéîĚĈĀîĆÖ 1,500 - 2,499 ÖøĆö õć÷Ĕî 28 üĆî Child: Percent of neonatal mortality with birth weight between 1,500 - 2,499 grams within 28 days 179 172 173 174 175 176 177 178 179

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 24 øĀĆÿ ßČęĂêĆüßĊĚüĆé Āîšć 2.2 Āöüé CA: Anesthesia care process (A) 2.2.1 CA01 Anesthesia care process CA0101 ĂĆêøćÖćøđÖĉéõćüąĀĆüĔÝĀ÷čéđêšîøąĀüŠćÜñŠćêĆéĔîñĎšðśü÷ìĊęöĊøąéĆï ASA physical status I, II ÖŠĂîñŠćêĆé Anesthesia: Intra-operative cardiac arrest ASA physical status I, II 180 CA0102 øšĂ÷úą×ĂÜÖćøđ÷Ċę÷öñĎšðśü÷ÖŠĂîÖćøĔĀš÷ćøąÜĆïÙüćöøĎšÿċÖĔîñĎšðśü÷ĔîìĊęøĆïÖćø ñŠćêĆéĒïïĕöŠÞčÖđÞĉî Anesthesia: Percent of pre-anesthetic visit elective in-patient cases 181 CA0103 øšĂ÷úą×ĂÜñĎšðśü÷ìĊęøĆïÖćøĔĀš÷ćøąÜĆïÙüćöøĎšÿċÖìĊęĕéšøĆïÖćøéĎĒúĔîĀšĂÜóĆÖôŚŪî Anesthesia: Percent of patients observed in recovery room 182 CA0104 øšĂ÷úą×ĂÜñĎšðśü÷ĕéšøĆïÖćøĔÿŠìŠĂĀć÷ĔÝàĚĈõć÷Ĕî 2 ßĆęüēöÜĀúĆÜÖćøëĂéìŠĂ Āć÷ĔÝ Anesthesia: Percent of re-intubation within 2 hours after extubation 183 CA0105 øšĂ÷úą×ĂÜñĎšðśü÷ìĊęéö÷ćÿúïĕéšøĆïÖćøđòŜćøąüĆÜøąéĆïÖŢćàÙćøŤïĂîĕéĂĂÖĕàéŤĔî úöĀć÷ĔÝĂĂÖ Anesthesia: Percent of using capnometry during general anesthesia 184 2.3 Āöüé CO: Operative Care Process (O) 2.3.1 CO01 Operative Care Process CO0101 øšĂ÷úą×ĂÜÖćøĔßšĒïïêøüÝÿĂïđóČęĂÙüćöðúĂéõĆ÷×ĂÜñĎšðśü÷đöČęĂöćøĆïÖćø êøüÝøĆÖþćĔîĀšĂÜñŠćêĆé Operation: Percent of using surgical safety check list 185 CO0105 øšĂ÷úąÖćøđÿĊ÷ßĊüĉê×ĂÜñĎšðśü÷ñŠćêĆéĔî 24ßĆęüēöÜ Operation: Percent of peri-operative mortality within 24 hours 186 CO0107 øšĂ÷úąÖćøñŠćêĆéàĚĈ Operation: Percent of re-operation 187 2.4 Āöüé CG: General care process (G) 2.4.1 CG01 Pressure ulcer/injury care process CG0101 ĂĆêøćÖćøđÖĉéĒñúÖéìĆïĔîēøÜó÷ćïćú Pressure Ulcer/Injury: Rate of Pressure ulcer 188

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 25 øĀĆÿ ßČęĂêĆüßĊĚüĆé Āîšć CG0102 ĂĆêøćÖćøđÖĉéĒñúÖéìĆïĔîēøÜó÷ćïćúĔîñĎšðśü÷ÖúčŠöđÿĊę÷Ü Pressure Ulcer/Injury: Rate of Pressure ulcer in risk patients 190 CG0103 ĂĆêøćÙüćößčÖ×ĂÜĒñúÖéìĆï Pressure Ulcer/Injury: Hospital-acquired pressure ulcer/Injury 191 CG0104 ĂĆêøćÙüćößčÖ×ĂÜĒñúÖéìĆïìĊęđÖĉéĔîēøÜó÷ćïćú Pressure Ulcer/Injury: Hospital-acquired pressure ulcer/Injury (HAPI) rate 193 2.5 Āöüé CE: Emergency care process (E) 2.5.1 CE01 ER care process CE0101 øšĂ÷úąñĎšðśü÷ĀšĂÜÞčÖđÞĉîìĊęöĊõćüąêĉéđßČĚĂĔîÖøąĒÿēúĀĉêĕéøšĆï÷ćêćîÝ š čúßĊóõć÷Ĕî 3ßĆęüēöÜ Sepsis: Percent of broad-spectrum antibiotic receiving within 3 hours 194 CE0102 ÙŠćđÞúĊę÷øą÷ąđüúćÖćøđךćøĆï-ĂĂÖÝćÖïøĉÖćø×ĂÜñĎšðśü÷ìĊęöćøĆïïøĉÖćøìĊęĀšĂÜÞčÖđÞĉî ER: Average Emergency Department (ED) TIME-IN, TIME-OUT 195 CE0103 øšĂ÷úą×ĂÜñĎšðśü÷ÞčÖđÞĉîöćÖìĊęĕéšøĆïïøĉÖćøìĊęĀšĂÜÞčÖđÞĉîøą÷ąđüúćõć÷Ĕî 60 îćìĊ ER: Percent of Emergency patients recieveing emergency service (ED TIME-IN, TIME-OUT) within 60 minutes 197 CE0104 øšĂ÷úąñĎšðśü÷ĀšĂÜÞčÖđÞĉî ìĊęöĊõćüąêĉéđßČĚĂĔîÖøąĒÿēúĀĉêĕéšøĆï÷ćêšćîÝčúßĊóõć÷Ĕî 1 ßĆęüēöÜ Sepsis: Percent of broad-spectrum antibiotic received within 1 hour in emergency room 198 2.6 Āöüé CI: Intensive care process (I) 2.6.1 CI01 Sepsis care process CI0101 øšĂ÷úąÖćøđÿĊ÷ßĊüĉê×ĂÜñĎšðśü÷ĔîÝćÖõćüąêĉéđßČĚĂĔîÖøąĒÿēúĀĉê Sepsis: Percent of mortality 199 2.7 Āöüé CP: Psychiatric Care Process (M)

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 26 øĀĆÿ ßČęĂêĆüßĊĚüĆé Āîšć 2.7.1 CP01 Child and adlescent psychiatric care process CP0101 øšĂ÷úąñĎšðÖÙøĂÜ×ĂÜđéĘÖÿöćíĉÿĆĚî/LD/MDD øć÷ĔĀöŠìĊęöćøĆïÖćøïĈïĆéøĆÖþćĔî øĂï 6 đéČĂî ĒúąöćøĆïÖćøøĆÖþćêćöîĆé Percent of carers of children with ADHD/LD/MDD having good compliance to treatment 200 2.7.2 CP02 Neurodevelopmental disorder care process CP0201 øšĂ÷úąđéĘÖìĊęÿÜÿĆ÷ēøÙĔîÖúčŠöóĆçîćÖćøĕéšøĆïÖćøüĉîĉÝÞĆ÷õć÷Ĕî 90 üĆî Percent of children with Neurodevelopmental Disorder being diagnosed within 90 days after registration 201

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 27 ĒñîñĆÜõćóøüö ÖúčŠöêĆüßĊĚüĆéøąïïÜćîÿĈÙâĆ (System: S) Āöüé ðøąđõì SI øąïïÙüïÙčöĒúąðŜĂÜÖĆîÖćøêĉéđßČĚĂ (Infectious and prevention control system) 01 VAP 02 BSI 03 CAUTI 04 SSI 05 HAI SL øąïïÖćøêøüÝüĉîĉÝÞĆ÷ìćÜ ĀšĂÜðäĉïĆêĉÖćø (Laboratory system) 01 Blood bank SH øąïïïøĉĀćøìøĆó÷ćÖøïčÙÙú (Human resource system) 01 HRM 02 HRD 03 HRH SF øąïïïøĉĀćøÖćøđÜĉîÖćøÙúĆÜ (Financial system) 01 Financial SC øąïïïøĉÖćøðøąßćßî (Customer service system) 01 Customer service SG øąïïĂõĉïćúĂÜÙŤÖø (Governance system) 01 Governance SS øąïïÖćøìĈĔĀšðøćýÝćÖđßČĚĂ (Sterilization system) 01 Sterilization and services system SM øąïï÷ć (Medication system) 01 Medication use 02 Medication management

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 28 øĀĆÿ ßČęĂêĆüßĊĚüĆé Āîšć 3. ïĆâßĊêĆüßĊĚüĆéøąïïÜćîÿĈÙĆâ (System: S) 3.1 Āöüé SI: Infection control system (I) 3.1.1 SI01 VAP SI0101 ĂĆêøćÖćøêĉéđßČĚĂðĂéĂĆÖđÿïÝćÖÖćøĔßšđÙøČęĂÜߊü÷Āć÷ĔÝ (õćóøüö) VAP: Rate of ventilator-associated pneumonia (All) 202 SI0102 ĂĆêøćÖćøêĉéđßČĚĂðĂéĂĆÖđÿïÝćÖÖćøĔßšđÙøČęĂÜߊü÷Āć÷ĔÝ ×ĂÜñĎšðśü÷ìĊęîĂî øĆÖþćĔî ICU VAP: Rate of ventilator-associated pneumonia in ICU 203 SI0103 ĂĆêøćÖćøêĉéđßČĚĂðĂéĂĆÖđÿïÝćÖÖćøĔßšđÙøČęĂÜߊü÷Āć÷ĔÝ ×ĂÜñĎšðśü÷ìĊęîĂî øĆÖþćîĂÖ ICU ×ĂÜēøÜó÷ćïćú VAP: Rate of ventilator-associated pneumonia outside ICU 204 3.1.2 SI02 BSI øĀĆÿ ßČęĂêĆüßĊĚüĆé Āîšć SI0201 ĂĆêøćÖćøêĉéđßČĚĂĔîÖøąĒÿđúČĂéÝćÖÖćøÙćÿć÷ÿüîĀúĂéđúČĂéÿŠüîÖúćÜ (õćóøüö) BSI: Rate of CABSI (All) 205 SI0202 ĂĆêøćÖćøêĉéđßČĚĂĔîÖøąĒÿđúČĂéÝćÖÖćøÙćÿć÷ÿüîĀúĂéđúČĂéÿŠüîÖúćÜ ×ĂÜ ñĎšðśü÷ìĊęîĂîøĆÖþćĔî ICU BSI: Rate of CABSI in ICU 206 SI0203 ĂĆêøćÖćøêĉéđßČĚĂĔîÖøąĒÿđúČĂéÝćÖÖćøÙćÿć÷ÿüîĀúĂéđúČĂéÿŠüîÖúćÜ ×ĂÜ ñĎšðśü÷ìĊęîĂîøĆÖþćîĂÖ ICU ×ĂÜēøÜó÷ćïćú BSI: Rate of CABSI outside ICU 207 3.1.3 SI03 CAUTI øĀĆÿ ßČęĂêĆüßĊĚüĆé Āîšć SI0301 ĂĆêøćÖćøêĉéđßČĚĂøąïïìćÜđéĉîðŦÿÿćüąÝćÖÖćøÙćÿć÷ÿüîðŦÿÿćüą (õćóøüö) CAUTI: Rate of CAUTI (All) 208 SI0302 ĂĆêøćÖćøêĉéđßČĚĂøąïïìćÜđéĉîðŦÿÿćüąÝćÖÖćøÙćÿć÷ÿüîðŦÿÿćüą ×ĂÜñĎšðśü÷ ìĊęîĂîøĆÖþćĔî ICU CAUTI: Rate of CAUTI in ICU 209

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 29 øĀĆÿ ßČęĂêĆüßĊĚüĆé Āîšć SI0303 ĂĆêøćÖćøêĉéđßČĚĂøąïïìćÜđéĉîðŦÿÿćüąÝćÖÖćøÙćÿć÷ÿüîðŦÿÿćüą ×ĂÜñĎšðśü÷ ìĊęîĂîøĆÖþćîĂÖ ICU ×ĂÜēøÜó÷ćïćú CAUTI: Rate of CAUTI outside ICU 210 3.2 Āöüé SL: Laboratory system (L) 3.2.1 SL01 Blood bank SL0101 ĂĆêøćÿŠüîÖćø×ĂĔßšēúĀĉêêŠĂÖćøĔßšēúĀĉêÝøĉÜĔîñĎšðśü÷ÖúčŠöñŠćêĆéðøąđõìêŠćÜ ė Crossmatch-to-Transfusion ratios (C:T) in selective surgery cases 211 3.3 Āöüé SH: Human resource system (H) 3.3.1 SH01 Human resource management (HRM) SH0101 ĂĆêøćÖćøúćĂĂÖ×ĂÜïčÙúćÖø HRM: Turnover rate 212 SH0102 øšĂ÷úąïčÙúćÖøìĊęïćéđÝĘïÝćÖÖćøìĈÜćî HRM: Percent of employee work-related Injury 213 SH0103 øšĂ÷úąïčÙúćÖøìĊęđÝĘïðśü÷ÝćÖÖćøìĈÜćî HRM: Percent of employee work-related Illness 214 SH0104 ĂĆêøćÖćøúćĂĂÖ ×ĂÜĒóì÷Ť/ìĆîêĒóì÷Ť HRM: Turnover rate of physician and dentist 215 SH0105 ĂĆêøćÖćøúćĂĂÖ ×ĂÜó÷ćïćúüĉßćßĊó HRM: Turnover rate of nurses 216 SH0106 ĂĆêøćÖćøúćĂĂÖ ×ĂÜïčÙúćÖøÿć÷ Allied Health HRM: Turnover rate of allied health personnel 217 SH0107 ĂĆêøćÖćøúćĂĂÖ ×ĂÜïčÙúćÖøÿć÷ÿîĆïÿîčî HRM: Turnover rate of back office personnel 218 3.3.2 SH02 Human resource development (HRD) SH0201 øšĂ÷úąÙüćöóċÜóĂĔÝ×ĂÜïčÙúćÖøĔîĂÜÙŤÖøĔîõćóøüö×ĂÜĒóì÷Ť/ìĆîêĒóì÷Ť (øąéĆï 4-5) HRD: Percent of physician/dentist satisfaction (level 4-5) 219 SH0202 øšĂ÷úąÙüćöóċÜóĂĔÝ ×ĂÜïčÙúćÖøĔîĂÜÙŤÖøĔîõćóøüö×ĂÜó÷ćïćúüĉßćßĊó (øąéĆï 4-5) HRD: Percent of nurse satisfaction (level 4-5) 220

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 30 øĀĆÿ ßČęĂêĆüßĊĚüĆé Āîšć SH0203 øšĂ÷úąÙüćöóċÜóĂĔÝ ×ĂÜïčÙúćÖøĔîĂÜÙŤÖøĔîõćóøüö×ĂÜïčÙúćÖøÿć÷ Allied Health (øąéĆï 4-5) HRD: Percent of allied health personel satisfaction (level 4-5) 221 SH0204 ÿĆéÿŠüîßĆęüēöÜÖćøòřÖĂïøöêŠĂÙîêŠĂðŘ×ĂÜĒóì÷Ť/ ìĆîêĒóì÷Ť HRD: Training hour per person per year of physician/dentist 222 SH0205 ÿĆéÿŠüîßĆęüēöÜÖćøòřÖĂïøöêŠĂÙîêŠĂðŘ×ĂÜó÷ćïćúüĉßćßĊó HRD: HRD: Training hour per person per Year of nurse 223 SH0206 øšĂ÷úąÙüćöóċÜóĂĔÝ ×ĂÜïčÙúćÖøĔîĂÜÙŤÖøĔîõćóøüö×ĂÜĒóì÷Ť/ ìĆîê Ēóì÷Ť (ÙŠćđÞúĊę÷) HRD: Percent of physician and dentist satisfaction (average) 224 SH0207 øšĂ÷úąÙüćöóċÜóĂĔÝ ×ĂÜïčÙúćÖøĔîĂÜÙŤÖøĔîõćóøüö×ĂÜĒóì÷Ť/ìĆîêĒóì÷Ť (øąéĆï 1-2) HRD: Percent of physician and dentist satisfaction (level 1-2) 225 SH0208 øšĂ÷úąÙüćöóċÜóĂĔÝ ×ĂÜïčÙúćÖøĔîĂÜÙŤÖøĔîõćóøüö×ĂÜó÷ćïćúüĉßćßĊó (ÙŠćđÞúĊę÷) HRD: Percentage of nurse satisfaction (average) 226 SH0209 øšĂ÷úąÙüćöóċÜóĂĔÝ ×ĂÜïčÙúćÖøĔîĂÜÙŤÖøĔîõćóøüö×ĂÜó÷ćïćúüĉßćßĊó (øąéĆï 1-2) HRD: Percentage of nurse satisfaction (level 1-2) 227 SH0210 øšĂ÷úąÙüćöóċÜóĂĔÝ ×ĂÜïčÙúćÖøĔîĂÜÙŤÖøĔîõćóøüö×ĂÜïčÙúćÖøÿć÷ Allied Health (ÙŠćđÞúĊę÷) HRD: Percent of allied health personnel satisfaction (average) 228 SH0211 øšĂ÷úąÙüćöóċÜóĂĔÝ ×ĂÜïčÙúćÖøĔîĂÜÙŤÖøĔîõćóøüö×ĂÜïčÙúćÖøÿć÷ Allied health (øąéĆï 1-2) HRD: Percent of allied health personnel satisfaction (level 1-2) 229 SH0212 øšĂ÷úąÙüćöóċÜóĂĔÝ ×ĂÜïčÙúćÖøĔîĂÜÙŤÖøĔîõćóøüö×ĂÜïčÙúćÖøÿć÷ ÿîĆïÿîčî (ÙŠćđÞúĊę÷) HRD: Percent of back office personnel satisfaction (average) 230 SH0213 øšĂ÷úąÙüćöóċÜóĂĔÝ ×ĂÜïčÙúćÖøĔîĂÜÙŤÖøĔîõćóøüö×ĂÜïčÙúćÖøÿć÷ ÿîĆïÿîčî (øąéĆï 4-5) HRD: Percentage of back office personnel satisfaction (level 4-5) 231

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 31 øĀĆÿ ßČęĂêĆüßĊĚüĆé Āîšć SH0214 øšĂ÷úąÙüćöóċÜóĂĔÝ ×ĂÜïčÙúćÖøĔîĂÜÙŤÖøĔîõćóøüö×ĂÜïčÙúćÖøÿć÷ ÿîĆïÿîčî (øąéĆï 1-2) HRD: Percentage of back office personnel satisfaction (level 1-2) 232 SH0215 ÿĆéÿŠüîßĆęüēöÜÖćøòřÖĂïøöêŠĂÙîêŠĂðŘ×ĂÜïčÙúćÖøÿć÷ Allied Health HRD: Training hour per person per year of allied health personnel 233 SH0216 ÿĆéÿŠüîßĆęüēöÜÖćøòřÖĂïøöêŠĂÙîêŠĂðŘ×ĂÜïčÙúćÖøÿć÷ÿîĆïÿîčî HRD: Training hour per person per year of back office personnel 234 3.3.3 SH03 Human resources and occupational health (HRH) SH0301 ĂĆêøćÙüćöëĊęÖćøïćéđÝĘï/ đÝĘïðśü÷×ĂÜïčÙúćÖøìĊęđÖĊę÷üđîČęĂÜÝćÖÜćî HRH: Injury (Illnesses) Frequency Rate (IFR) 235 SH0302 ĂĆêøćÙüćöøčîĒøÜ×ĂÜÖćøïćéđÝĘï×ĂÜïčÙúćÖøÖúčŠöÿĆöñĆÿñĎšðśü÷ēé÷êøÜ HRH: Injury Severity Rate: ISR of Direct Contact with Patients 236 SH0303 ĂĆêøćÙüćöøčîĒøÜ×ĂÜÖćøïćéđÝĘï×ĂÜïčÙúćÖøÖúčŠöìĊęĕöŠĕéšÿĆöñĆÿñĎšðśü÷ēé÷êøÜ HRH: Injury Severity Rate: ISRof non Direct Contact with Patients 238 SH0306 ĂĆêøćÙüćöëĊęÖćøïćéđÝĘï/ đÝĘïðśü÷×ĂÜïčÙúćÖøìĊęđÖĊę÷üđîČęĂÜÝćÖÜćî ×ĂÜ ïčÙúćÖøÖúčŠöÿĆöñĆÿñĎšðśü÷ēé÷êøÜ HRH: Injury (illnesses) Frequency Rate: IFR of direct contact with patients 240 SH0307 ĂĆêøćÙüćöëĊęÖćøïćéđÝĘï/ đÝĘïðśü÷×ĂÜïčÙúćÖøìĊęđÖĊę÷üđîČęĂÜÝćÖÜćî ×ĂÜ ïčÙúćÖøÖúčŠöìĊęĕöŠĕéšÿĆöñĆÿñĎšðśü÷ēé÷êøÜ HRH: Injury (Illnesses) Frequency Rate : IFR of Non-direct Contact with Patients 242 3.4 Āöüé SF: Financial system (F) 3.4.1 SF01 Finance and accounting SF0101 ĂĆêøćÿŠüîìčîĀöčîđüĊ÷î Financial: Current ratio 244 SF0102 ĂĆêøćÿŠüîìčîĀöčîđüĊ÷îđøĘü (ĂĆêøćÿŠüîÿĉîìøĆó÷ŤÿõćóÙúŠĂÜ) Financial: Quick ratio 245 SF0103 ĂĆêøćĀöčîđüĊ÷î×ĂÜÿĉîìøĆó÷Ťëćüø Financial: Fixed asset turnover 246

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 32 øĀĆÿ ßČęĂêĆüßĊĚüĆé Āîšć SF0104 øą÷ąđüúćëĆüđÞúĊę÷ĔîÖćøđøĊ÷ÖđÖĘïúĎÖĀîĊĚÙŠćøĆÖþćÿčìíĉ Financial: Day in account receivable (average collection period for account receivables) 247 SF0105 ĂĆêøćÿŠüîøąĀüŠćÜÖĈĕøÿčìíĉÖĆï÷Ăé×ć÷ÿčìíĉ Financial: Net profit margin 248 SF0106 ĂĆêøćñúêĂïĒìîÝćÖÿĉîìøĆó÷Ťøüö Financial: Return on asset (ROA) 249 3.5 Āöüé SC: Customer service system (C) 3.5.1 SC01 Customer Service SC0101 øšĂ÷úąÙüćöóċÜóĂĔÝ×ĂÜñĎšðśü÷îĂÖ (õćóøüö) Customer: Percent of outpatient satisfaction (overall) 250 SC0102 øšĂ÷úąÙüćöóċÜóĂĔÝ×ĂÜñĎšðśü÷Ĕî (õćóøüö) Customer: Percent of inpatient satisfaction (overall) 251 SC0103 øšĂ÷úą×ĂÜñĎšðśü÷îĂÖìĊęÝąÖúĆïöćĔßšïøĉÖćøàĚĈ Customer: Percent of outpatients who return to receive care 252 SC0104 øšĂ÷úą×ĂÜñĎšðśü÷ĔîìĊęÝąÖúĆïöćĔßšïøĉÖćøàĚĈ Customer: Percent of inpatients who return to receive care 253 SC0105 øšĂ÷úą×ĂÜñĎšðśü÷îĂÖìĊęÝąĒîąîĈâćêĉĀøČĂÙîøĎšÝĆÖöćĔßšïøĉÖćø Customer: Percent of outpatients who would recommend friends or family to receive care at this facility 254 SC0106 øšĂ÷úą×ĂÜñĎšðśü÷ĔîìĊęÝąĒîąîĈâćêĉĀøČĂÙîøĎšÝĆÖöćĔßšïøĉÖćø Customer: Percent of inpatients who would recommend friends or family to receive care at this facility 255 3.6 Āöüé SG: Governance system (G) 3.6.1 SG01 Governance SG0104 ÿĆéÿŠüî×ĂÜ×÷ąøĊĕàđÙĉú Governance: Percent of recycled waste 256 3.7 Āöüé SS: Sterilization system (S) 3.7.1 SS01 Sterilization and services system

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 33 øĀĆÿ ßČęĂêĆüßĊĚüĆé Āîšć SS0101 øšĂ÷úąÖćøêøüÝÿĂïðøąÿĉìíĉõćóÖćøìĈðøćýÝćÖđßČĚĂñŠćîđÖèæŤ CSSD: Percent of examination of effective sterilization 257 SS0102 øšĂ÷úąÖćøÝĆéĂčðÖøèŤđÙøČęĂÜöČĂìćÜÖćøĒóì÷ŤëĎÖêšĂÜÙøïëšüî CSSD: Percent of exact medical equipment prepared for specific procedures 258 SS0103 øšĂ÷úąÖćøÝŠć÷ĂčðÖøèŤđÙøČęĂÜöČĂìćÜÖćøĒóì÷ŤĔĀšĀîŠü÷ÜćîëĎÖêšĂÜ CSSD: Percent of medical supplies which are accurately provided by the CSSD 259 3.8 Āöüé SM: Medication System (M) 3.8.1 SM01 Medication Use øĀĆÿ 7) ßČęĂêĆüßĊĚüĆé Āîšć SM0102 øšĂ÷úąÖćøĔßš÷ćðäĉßĊüîąĔîñĎšðśü÷ēøÙêĉéđßČĚĂìćÜđéĉîĀć÷ĔÝÿŠüîïî Medication Use: Percent of Antibiotic prescribing rate on Upper respiratory infection 260 SM0103 øšĂ÷úąÖćøĔßš÷ćðäĉßĊüîąĔîñĎšðśü÷ĂčÝÝćøąøŠüÜđÞĊ÷ïóúĆî Medication Use: Percent of Antibiotic prescribing on Acute diarrhea 261 3.8.2 SM02 Medication management SM0201 ÝĈîüîđéČĂîÿĈøĂÜÙúĆÜ÷ć Medication management: Inventory turn 262

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 34 ĒñîñĆÜõćóøüö ÖúčŠöêĆüßĊĚüĆéÿøšćÜđÿøöÿĉ č×õćó (Health Promotion: H) Āöüé ðøąđõì HE êĆüßĊĚüĆéÿøšćÜđÿøĉöÿč×õćóïčÙúćÖø 01 Employee Health Status HC êĆüßĊĚüĆéÿøšćÜđÿøĉöÿč×õćóðøąßćßî 01 Customer Health Status HD êĆüßĊĚüĆéÿøšćÜđÿøĉöÿč×õćóêćöÖúčŠöēøÙ (Disease-based health promotion) HP êĆüßĊĚüĆéÿøšćÜđÿøĉöÿč×õćóêćöÖúčŠöüĆ÷ (Population-based health promotion) HH êĆüßĊĚüĆéÿøšćÜđÿøĉöÿč×õćóêćöðŦÝÝĆ÷đÿĊę÷Ü õĆ÷ÿč×õćó (Health risk factors) HH ต 01 Tobacco Use ัวชี้วัดสรางเสริมสุขภาพตามปจจัยเสี่ยง 01 Tobacco Use ภัยสุขภาพ (Health risk factors)

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 35 øĀĆÿ ßČęĂêĆüßĊĚüĆé Āîšć 4. ïĆâßĊêĆüßĊĚüĆéÿøšćÜđÿøĉöÿč×õćó (Health promotion: H) 4.1 Āöüé HE: ÿøšćÜđÿøĉöÿč×õćóïčÙúćÖø (Employee health promotion: E) 4.1.1 HE01 Employee health status HE0101 øšĂ÷úąïčÙúćÖøĕéšøĆïÖćøêøüÝøŠćÜÖć÷ðøąÝĈðŘ Employee: Percent of employee check-up 264 HE0102 øšĂ÷úąïčÙúćÖøìĊęöĊéĆßîĊöüúÖć÷ (BMI) đÖĉîđÖèæŤöćêøåćî Employee: Percent of employee have exceeding BMI 265 HE0103 øšĂ÷úąïčÙúćÖøìĊęöĊóùêĉÖøøöÖćøÿĎïïčĀøĊę Employee: Percent of employee have behavior-smoky 266 HE0104 øšĂ÷úąïčÙúćÖøđóýßć÷öĊõćüąĂšüîúÜóčÜ Employee: Percent of employee (male) obesity 267 HE0105 øšĂ÷úąïčÙúćÖøđóýĀâĉÜöĊõćüąĂšüîúÜóčÜ Employee: Percent of employee (female) obesity 268 HE0106 øšĂ÷úąïčÙúćÖøĕéšøĆïüĆÙàĊîĕךĀüĆéĔĀ⊠Employee: Percent of employee received Influenza immunization 269 4.2 Āöüé HC: ÿøšćÜđÿøĉöÿč×õćóñĎšøĆïïøĉÖćø (Customer health promotion: C) 4.2.1 HC01 Customer health status HC0101 ÙüćöÿćöćøëĔîÖćøéĎĒúêîđĂÜ/ ÖćøéĎĒúñĎšðśü÷×ĂÜâćêĉēøÙ Asthma Customer: Asthma patients or their relative(s) who are able to care for the patient's needs 270 HC0102 ÙüćöÿćöćøëĔîÖćøéĎĒúêîđĂÜ/ ÖćøéĎĒúñĎšðśü÷×ĂÜâćêĉēøÙ COPD Customer: COPD patients or their relative(s) who are able to care for the patient's needs 271 4.3 Āöüé HD: êĆüßĊĚüĆéÿøšćÜđÿøĉöÿč×õćóêćöÖúčŠöēøÙ (Disease-based health promotion) 4.4 Āöüé HP: êĆüßĊĚüĆéÿøšćÜđÿøĉöÿč×õćóêćöÖúčŠöüĆ÷ (Population-based health promotion) 4.5 Āöüé HH: êĆüßĊĚüĆéÿøšćÜđÿøĉöÿč×õćóêćöðŦÝÝĆ÷đÿĊę÷ÜõĆ÷ÿč×õćó (Health risk factors) HH0101.1 øšĂ÷úąÖćøÙĆéÖøĂÜÿëćîąÖćøïøĉēõÙ÷ćÿĎï×ĂÜñĎšøĆïïøĉÖćøìĊęöĊĂć÷č 15 ðŘ×ċĚîĕð ìĊęöćĔßš 272 4.5 หมวด HH: ตัวชี้วัดสรางเสริมสุขภาพตามปจจัยเสี่ยงภัยสุขภาพ (Health risk factors) HH0101.1 รอยละการคัดกรองสถานะการบริโภคยาสูบของผูรับบริการที่มีอายุ 15 ปขึ้นไป ที่มาใช 272

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 36 บริการผูปวยนอกของสถานพยาบาล Tobacco Use: Percent of Tobacco Use Screened of Service Recipients aged ≥ 15 years old at the Outpatient Service. HH0101.2 รอยละการคัดกรองสถานะการบริโภคยาสูบของผูรับบริการที่มีอายุ 15 ปขึ้นไป ที่มาใชบริการผูปวยในของสถานพยาบาล Tobacco Use: Percent of Tobacco Use Screened of Service Recipients aged ≥ 15 years old at the Outpatient Service. HH0102 รอยละของผูรับบริการที่มีภาวะติดนิโคตินที่ไดรับบริการบำบัดภาวะติดนิโคติน Tobacco Use: Percentage of nicotine dependence patients receiving nicotine dependence treatment. HH0103.1 รอยละของผูรับบริการกลุมโรคเบาหวานที่มีภาวะติดนิโคตินและไดรับบริการ บำบัดภาวะติดนิโคติน Tobacco Use: Percentage of nicotine dependence in DM patients receiving nicotine dependence treatment. HH0103.2 รอยละของผูรับบริการกลุมโรคความดันโลหิตสูงที่มีภาวะติดนิโคตินและไดรับ บริการบำบัดภาวะติดนิโคติน Tobacco Use: Percentage of nicotine dependence in Hypertension patients receiving nicotine dependence treatment. HH0103.3 รอยละของผูรับบริการกลุมโรคหืดที่มีภาวะติดนิโคตินและไดรับบริการบำบัด ภาวะติดนิโคติน Tobacco Use: Percentage of nicotine dependence in Asthma patients receiving nicotine dependence treatment HH0103.4 รอยละของผูรับบริการกลุมโรคถุงลมโปงพองที่มีภาวะติดนิโคตินและไดรับ บริการบำบัดภาวะติดนิโคติน Tobacco Use: Percentage of nicotine dependence in COPD patients receiving nicotine dependence treatment. HH0103.5 รอยละของผูรับบริการกลุมหญิงตั้งครรภที่มีภาวะติดนิโคตินและไดรับบริการ บำบัดภาวะติดนิโคติน Tobacco Use: Percentage of nicotine dependence in Pregnant patients receiving nicotine dependence treatment. รหัส ชื่อตัวชี้วัด หนา 273 274 275 276 277 278 279

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 37 HH0103.6 รอยละของผูรับบริการกลุมโรคถุงลมโปงพองที่มีภาวะติดนิโคตินและไดรับบริการบำบัด ภาวะติดนิโคติน Tobacco Use: Percentage of nicotine dependence in Asthma patients receiving nicotine dependence treatment. HH0104.1 รอยละของผูปวยกลุมโรคเบาหวานที่รับบริการบำบัดรักษาภาวะติดนิโคตินและสามารถ หยุดบริโภคยาสูบตอเนื่อง 6 เดือน Tobacco use: continuous abstinence rate (CAR) at 6 months (DM Patients) HH0104.2 รอยละของผูปวยกลุมโรคความดันโลหิตสูงที่รับบริการบำบัดรักษาภาวะติดนิโคตินและ สามารถหยุดบริโภคยาสูบตอเนื่อง 6 เดือน Tobacco use: continuous abstinence rate (CAR) at 6 months (Hypertension Patients) HH0104.3 รอยละของผูปวยกลุมโรคหืดที่รับบริการบำบัดรักษาภาวะติดนิโคตินและสามารถหยุด บริโภคยาสูบตอเนื่อง 6 เดือน Tobacco use: continuous abstinence rate (CAR) at 6 months (Asthma Patients) HH0104.4 รอยละของผูปวยกลุมโรคถุงลมโปงพองที่รับบริการบำบัดรักษาภาวะติดนิโคตินและ สามารถหยุดบริโภคยาสูบตอเนื่อง 6 เดือน Tobacco use: continuous abstinence rate (CAR) at 6 months (COPD Patients) HH0104.5 รอยละของผูปวยกลุมหญิงตั้งครรภที่รับบริการบำบัดรักษาภาวะติดนิโคตินและสามารถ หยุดบริโภคยาสูบตอเนื่อง 6 เดือน Tobacco use: Tobacco use: continuous abstinence rate (CAR) at 6 months (Pregnant Patients) รหัส ชื่อตัวชี้วัด หนา 280 281 282 283 284 285

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 38 ĒñîñĆÜõćóøüö ÖúčŠöêĆüßĊĚüĆéÖúčŠöēøÙìĊęÙüøøĆÖþćĒïïñĎšðśü÷îĂÖ (Ambulatory care: A) Āöüé ðøąđõì AA êĆüßĊĚüĆéÖúčŠöēøÙìĊęÙüøøĆÖþćĒïï ñĎšðśü÷îĂÖ 01 Ambulatory care sensitive condition (ACSC) 5. ïĆâßĊêĆüßĊĚüĆéÖúčŠöēøÙìĊęÙüøøĆÖþćĒïïñĎšðśü÷îĂÖ (Ambularoty Care: A) 5.1 Āöüé AA: ÖúčŠöēøÙìĊęÙüøøĆÖþćĒïïñĎšðśü÷îĂÖ (Ambulatory Care: A) 5.1.1 AA01 Ambulatory Care Sensitive Condition (ACSC) øĀĆÿ ßČęĂêĆüßĊĚüĆé Āîšć AA0101 ĂĆêøćÖćøîĂîēøÜó÷ćïćúéšü÷õćüąìĊęÙüøÙüïÙčöéšü÷ïøĉÖćøñĎšðśü÷îĂÖ (ēøÙúößĆÖ) Epilepsy: Hospitalization rate 286 AA0102 ĂĆêøćÖćøîĂîēøÜó÷ćïćúéšü÷õćüąìĊęÙüøÙüïÙčöéšü÷ïøĉÖćøñĎšðśü÷îĂÖ (ēøÙðĂéĂčéÖĆĚîđøČĚĂøĆÜ) COPD: Hospitalization rate 287 AA0103 ĂĆêøćÖćøîĂîēøÜó÷ćïćúéšü÷õćüąìĊęÙüøÙüïÙčöéšü÷ïøĉÖćøñĎšðśü÷îĂÖ (ēøÙĀČé) Asthma: Hospitalization rate 288 AA0104 ĂĆêøćÖćøîĂîēøÜó÷ćïćúéšü÷õćüąìĊęÙüøÙüïÙčöéšü÷ïøĉÖćøñĎšðśü÷îĂÖ (ēøÙđïćĀüćî) Diabetes Mellitus (DM): Hospitalization rate 289 AA0105 ĂĆêøćÖćøîĂîēøÜó÷ćïćúéšü÷õćüąìĊęÙüøÙüïÙčöéšü÷ïøĉÖćøñĎšðśü÷îĂÖ (ēøÙÙüćöéĆîēúĀĉêÿĎÜ) Hypertension: Hospitalization rate 290

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 39 Āöüé DH: Cardiovascular disease (Heart disease:H) ðøąđõì DH01 Acute coronary syndrome (ACS) ĀöüéêĆüßĊĚüĆé Cardiovascular disease (Heart disease) ðøąđõìêĆüßĊĚüĆé Acute coronary syndrome (ACS) øĀĆÿêĆüßĊĚüĆé DH0101 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąÖćøđÿĊ÷ßĊüĉê×ĂÜñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Acute coronary syndrome: Percent of mortality îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ Acute coronary syndrome (ACS) Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖ øĆÖþćĔîēøÜó÷ćïćúîćîêĆĚÜĒêŠ 4 ßĆęüēöÜ×ċĚîĕð) Ăć÷č œ 18 ðŘìĊęöĊPrincipal diagnosis (Pdx) đðŨîõćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ĕéšĒÖŠ 1.1) õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ÷Ö×ċĚî (STEMI) 1.2) õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ĕöŠ ÷Ö×ċĚî (NSTE-ACS) ĀøČĂñĎšðśü÷ìĊęĂ÷ĎŠĔîÖúčŠöøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊę øąïčĕüšîĊĚ 2. ÖćøđÿĊ÷ßĊüĉê×ĂÜñĎšðśü÷ Acute coronary syndrome (ACS) Āöć÷ëċÜ ÖćøđÿĊ÷ßĊüĉêÝćÖ ìčÖÿćđĀêč×ĂÜñĎšðśü÷ ACS ìĊęöĊPdx êćöìĊęøąïčĕüšĀøČĂñĎšðśü÷ìĊęöĊēøÙøŠüöĀøČĂēøÙĒìøÖđðŨî ACS Ēúą öĊÿćđĀêčÖćøêć÷ÝćÖõćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî 3. ÖćøÝĈĀîŠć÷ìčÖÿëćîą Āöć÷ëċÜ ÖćøìĊęñĎšðśü÷ĔîĂĂÖÝćÖēøÜó÷ćïćú ĔîìčÖÿëćîą üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñúÖøąïüîÖćøéĎĒúøĆÖþćÖúčŠöñĎšðśü÷ ACS ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîÙøĆĚÜ×ĂÜÖćøÝĈĀîć÷é Š šü÷Öćøđÿ÷ßĊ Ċüĉê×ĂÜñĎšðśü÷ ACS ÝćÖìÖĀĂñ č Ďšðśü÷ĔîđéČĂîîîĆĚ êĆüĀćø b = ÝĈîüîÙøĆĚÜ×ĂÜÖćøÝĈĀîŠć÷ìčÖÿëćîą×ĂÜñĎšðśü÷ ACS ÝćÖìčÖĀĂñĎšðśü÷ĔîߊüÜđéČĂî đéĊ÷üÖĆîîĆĚî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = I21.0, I21.1, I21.2, I21.3, I21.4, I21.9 ìĊęđÿĊ÷ßĊüĉêÝćÖìčÖÿćđĀêč ĀøČĂ Sdx = I21.0, I21.1, I21.2, I21.3, I21.4, I21.9 Ēúą đÿĊ÷ßĊüĉêéšü÷ÿćđĀêčÝćÖ ACS êĆüĀćø I21.0, I21.1, I21.2, I21.3, I21.4, I21.9 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ)* üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference NQF, THIP I ,ĒîüìćÜđüßðäĉïĆêÖćøé ĉ ĎĒúøĆÖþćñðĎš śü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ó.ý. 2563 üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2564 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę1 (êčúćÙö 2564): ðøĆïîĉ÷ćöÿĂéÙúšĂÜêćöĒîüđüßðäĉïĆêĉÖćøéĎĒúøĆÖþć ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞ÷ïóú Ċ Ćî ó.ý. 2563 Āöć÷đĀêč G DH0101

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 40 ĀöüéêĆüßĊĚüĆé Cardiovascular Disease (Heart disease) ðøąđõìêĆüßĊĚüĆé Acute coronary syndrome (ACS) øĀĆÿêĆüßĊĚüĆé DH0101.1 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąÖćøđÿĊ÷ßĊüĉê×ĂÜñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ÷Ö×ċĚî (STEMI) ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Acute coronary syndrome: Percent of mortality (STEMI) îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉéST segment ÷Ö×ċĚî (STEMI) Āöć÷ëċÜ ñĎšðśü÷ Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔîēøÜó÷ćïćú îćîêĆĚÜĒêŠ 4 ßĆęüēöÜ×ċĚîĕð) Ăć÷č œ 18 ðŘìĊęöĊ Principal diagnosis (Pdx) đðŨîõćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ÷Ö×ċĚî (STEMI) ĀøČĂñĎšðśü÷ìĊęĂ÷ĎŠĔîÖúčŠöøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøđÿĊ÷ßĊüĉê×ĂÜñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉéST segment ÷Ö×ċĚî (STEMI) Āöć÷ëċÜ ÖćøđÿĊ÷ßĊüĉêÝćÖìčÖÿćđĀêč×ĂÜñĎšðśü÷ STEMI ìĊęöĊPdx êćöìĊęøąïčĕüšĀøČĂñĎšðśü÷ìĊęöĊ ēøÙøŠüöĀøČĂēøÙĒìøÖđðŨî STEMI Ēúą öĊÿćđĀêčÖćøêć÷ÝćÖõćüąĀĆüĔÝ×ćéđúĂéđÞ Č Ċ÷ïóúîĆ ßîĉé ST segment ÷Ö×ċĚî 3. ÖćøÝĈĀîŠć÷ìčÖÿëćîą Āöć÷ëċÜ ÖćøìĊęñĎšðśü÷ĔîĂĂÖÝćÖēøÜó÷ćïćú ĔîìčÖÿëćîą üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñúÖøąïüîÖćøéĎĒúøĆÖþćÖúčŠöñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ÷Ö×ċĚî (STEMI) ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîÙøĆĚÜ×ĂÜÖćøÝĈĀîŠć÷éü÷Öćøđÿ š Ċ÷ßĊüĉê×ĂÜñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ßîĉé ST segment ÷Ö×ċĚî (STEMI) ÝćÖìčÖĀĂñĎšðśü÷ĔîđéČĂîîĆĚî êĆüĀćø b = ÝĈîüîÙøĆĚÜ×ĂÜÖćøÝĈĀîŠć÷ìčÖÿëćîą×ĂÜñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ÷Ö×ċĚî (STEMI) ÝćÖìčÖĀĂñĎšðśü÷ĔîߊüÜđéČĂîđéĊ÷üÖĆîîĆĚî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = I21.0, I21.1, I21.2, I21.3 ìĊęđÿĊ÷ßĊüĉêÝćÖìčÖÿćđĀêč ĀøČĂ Sdx = I21.0, I21.1, I21.2, I21.3 Ēúą đÿ÷ßĊ Ċüĉêéšü÷ÿćđĀêčÝćÖõćüąĀĆüĔÝ×ćéđúČĂé đÞĊ÷ïóúĆîßîĉé ST segment ÷Ö×ċĚî (STEMI) êĆüĀćø I21.0, I21.1, I21.2, I21.3 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ)* üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference ĒîüìćÜđüßðäĉïĆêĉÖćøéĎĒúøĆÖþćñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞ÷ïóú Ċ Ćî ó.ý. 2563 üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2564 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DH0101.1 DH0101.1

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 41 ĀöüéêĆüßĊĚüĆé Cardiovascular disease (Heart disease) ðøąđõìêĆüßĊĚüĆé Acute coronary syndrome (ACS) øĀĆÿêĆüßĊĚüĆé DH0101.2 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąÖćøđÿĊ÷ßĊüĉê×ĂÜñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ĕö÷Ö× Š ċĚî (NSTE-ACS) ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Acute coronary syndrome : Percent of mortality (NSTE-ACS) îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉéST segment ĕöŠ÷Ö×ċĚî (NSTE-ACS) Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔîēøÜó÷ćïćúîćîêÜĒê ĆĚ Š 4 ßĆęüēöÜ×ċĚîĕð) Ăć÷č œ 18 ðŘ ìĊęöĊPrincipal diagnosis (Pdx) đðŨî õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ĕöŠ ÷Ö×ċĚî (NSTE-ACS) ĀøČĂñĎšðśü÷ìĊęĂ÷ĎŠĔîÖúčŠöøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊę øąïčĕüšîĊĚ 2. ÖćøđÿĊ÷ßĊüĉê×ĂÜñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ĕöŠ÷Ö×ċĚî (NSTE-ACS) Āöć÷ëċÜ ÖćøđÿĊ÷ßĊüĉêÝćÖìčÖÿćđĀêč×ĂÜñĎšðśü÷ NSTE-ACS ìĊęöĊPdx êćöìĊę øąïčĕüšĀøČĂñĎšðśü÷ìĊęöĊēøÙøŠüöĀøČĂēøÙĒìøÖđðŨî NSTE-ACS Ēúą öĊÿćđĀêčÖćøêć÷ÝćÖ õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ĕöŠ÷Ö×ċĚî 3. ÖćøÝĈĀîŠć÷ìčÖÿëćîą Āöć÷ëċÜ ÖćøìĊęñĎšðśü÷ĔîĂĂÖÝćÖēøÜó÷ćïćú ĔîìčÖÿëćîą üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñúÖøąïüîÖćøéĎĒúøĆÖþćÖúčŠöñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ĕö÷Ö× Š ċĚî (NSTE-ACS) ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîÙøĆĚÜ×ĂÜÖćøÝĈĀîŠć÷éü÷Öćøđÿ š Ċ÷ßĊüĉê×ĂÜñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆî ßîĉé ST segment ĕöŠ÷Ö×ċĚî (NSTE-ACS) ÝćÖìčÖĀĂñĎšðśü÷ĔîđéČĂîîĆĚî êĆüĀćø b = ÝĈîüîÙøĆĚÜ×ĂÜÖćøÝĈĀîŠć÷ìčÖÿëćîą×ĂÜñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ĕö÷Ö× Š ċĚî (NSTE-ACS) ÝćÖìčÖĀĂñĎšðśü÷ĔîߊüÜđéČĂîđéĊ÷üÖĆîîĆĚî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = I21.4, I21.9 ìĊęđÿĊ÷ßĊüĉêÝćÖìčÖÿćđĀêč ĀøČĂ Sdx = I21.4, I21.9 Ēúą đÿĊ÷ßĊüĉêéšü÷ÿćđĀêčÝćÖõćüąĀĆüĔÝ×ćéđúČĂéđÞĊ÷ïóúĆîßîĉé ST segment ĕöŠ÷Ö×ċĚî (NSTE-ACS) êĆüĀćø I21.4, I21.9 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ)* üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference ĒîüìćÜđüßðäĉïĆêĉÖćøéĎĒúøĆÖþćñĎšðśü÷õćüąĀĆüĔÝ×ćéđúČĂéđÞ÷ïóú Ċ Ćî ó.ý. 2563 üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2564 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DH0101.2 DH0101.2